<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-23803" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Neonatal Jaundice</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ansong-Assoku</surname>
            <given-names>Betty</given-names>
          </name>
          <aff>New York University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shah</surname>
            <given-names>Sanket D.</given-names>
          </name>
          <aff>University of Florida</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Adnan</surname>
            <given-names>Mohammad</given-names>
          </name>
          <aff>Indiana University Health</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ankola</surname>
            <given-names>Pratibha A.</given-names>
          </name>
          <aff>Lincoln Medical &#x00026; Mental Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Betty Ansong-Assoku declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sanket Shah declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mohammad Adnan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Pratibha Ankola declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-23803.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Neonatal jaundice is a clinical manifestation of elevated total serum bilirubin, termed neonatal&#x000a0;hyperbilirubinemia, which results from bilirubin that is deposited into an infant's skin. The characteristic features of neonatal jaundice include yellowish skin, sclerae, and mucous membranes. Neonatal jaundice is usually a mild, transient, and self-limiting condition known as physiologic jaundice. However, this should be distinguished from the more severe pathologic jaundice. The two types of neonatal hyperbilirubinemia are&#x000a0;unconjugated hyperbilirubinemia and&#x000a0;conjugated hyperbilirubinemia. In most neonates, unconjugated hyperbilirubinemia is the cause of clinical jaundice.&#x000a0;However, some infants have conjugated hyperbilirubinemia, which is always pathologic and signifies an underlying medical or surgical etiology. Failure to identify and treat pathologic jaundice may result in bilirubin encephalopathy and associated neurological sequelae.</p>
        <p>When neonatal jaundice is clinically identified, the underlying etiology of neonatal hyperbilirubinemia must be determined. Unconjugated hyperbilirubinemia is diagnosed by assessing bilirubin levels with a transcutaneous measurement device or blood samples for total serum bilirubin. Conjugated hyperbilirubinemia is typically diagnosed through laboratory studies, including serum aminotransferase, prothrombin time, urine cultures, tests for inborn errors of metabolism, and, in some cases, imaging studies.&#x000a0;Phototherapy and exchange transfusions are the mainstays of treatment of unconjugated hyperbilirubinemia, and a subset of patients also respond to intravenous immunoglobulin (IVIG). Treatment of conjugated hyperbilirubinemia is more complex and depends on the etiology of the jaundice.&#x000a0;This activity for healthcare professionals is designed to enhance the learner's competence when managing neonatal jaundice, equipping them with updated knowledge, skills, and strategies for timely identification, effective interventions, and improved interprofessional coordination of care, leading to better patient outcomes and reduced morbidity.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify pathologic jaundice and differentiate it from physiologic jaundice.</p></list-item><list-item><p>Delineate the etiologies of neonatal jaundice.</p></list-item><list-item><p>Implement evidence-based management options for neonatal jaundice.</p></list-item><list-item><p>Identify how the interprofessional team can work collaboratively to prevent the potentially profound complications of neonatal jaundice by applying knowledge about its prevention, presentation, evaluation, and management.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23803&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23803">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-23803.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Neonatal jaundice is a clinical manifestation of elevated total serum bilirubin (TSB), termed neonatal&#x000a0;hyperbilirubinemia, which results from bilirubin that is deposited into an infant's skin. The characteristic features of neonatal jaundice include yellowish skin, sclerae, and mucous membranes. Jaundice derives from the French word <italic toggle="yes">jaune</italic>, meaning yellow. Neonatal jaundice is the most&#x000a0;frequently encountered medical&#x000a0;condition in the first 2 weeks of life and a common cause of readmission to the hospital after birth.<xref ref-type="bibr" rid="article-23803.r1">[1]</xref>&#x000a0;Approximately&#x000a0;60% of term and 80% of preterm newborns develop clinical jaundice in the first week after birth.<xref ref-type="bibr" rid="article-23803.r2">[2]</xref>&#x000a0;Neonatal jaundice is usually a mild, transient, and self-limiting condition known as physiologic jaundice. However, this should be distinguished from the more severe pathologic jaundice. The two types of neonatal hyperbilirubinemia are&#x000a0;unconjugated hyperbilirubinemia&#x000a0;(UHB) and&#x000a0;conjugated hyperbilirubinemia (CHB).</p>
        <p>When neonatal jaundice is clinically identified, the underlying etiology of neonatal hyperbilirubinemia must be determined. In most neonates, unconjugated hyperbilirubinemia is the cause of clinical jaundice. However, some infants have conjugated hyperbilirubinemia, which is always pathologic and signifies an underlying medical or surgical etiology. Failure to identify and treat pathologic jaundice may result in bilirubin encephalopathy and associated neurological sequelae. The&#x000a0;causes of pathologic UHB and CHB are numerous and varied. Preterm infants and those with congenital enzyme deficiencies&#x000a0;are particularly prone to the harmful effects of unconjugated bilirubin on the central nervous system.<xref ref-type="bibr" rid="article-23803.r3">[3]</xref><xref ref-type="bibr" rid="article-23803.r4">[4]</xref></p>
        <p>Unconjugated hyperbilirubinemia is diagnosed by assessing bilirubin levels with a transcutaneous measurement device or blood samples for total serum bilirubin. Conjugated hyperbilirubinemia is typically diagnosed through laboratory studies, including serum aminotransferase, prothrombin time, urine cultures, tests for inborn errors of metabolism, and, in some cases, imaging studies. Severe hyperbilirubinemia can cause bilirubin-induced neurological dysfunction (BIND) and, if not treated adequately, may lead to acute and chronic bilirubin encephalopathy.<xref ref-type="bibr" rid="article-23803.r5">[5]</xref>&#x000a0;Phototherapy and exchange transfusions are the mainstays of treatment of UHB, and a subset of patients also respond to intravenous immunoglobulin (IVIG). Treatment of CHB is more complex and depends on the etiology of the jaundice. Despite advances in the care and management of hyperbilirubinemia, it remains a significant cause of neonatal morbidity and mortality.<xref ref-type="bibr" rid="article-23803.r6">[6]</xref></p>
      </sec>
      <sec id="article-23803.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The underlying etiology of neonatal jaundice is neonatal hyperbilirubinemia, which has&#x000a0;2 distinct types: unconjugated and conjugated hyperbilirubinemia, also known as indirect and direct hyperbilirubinemia, respectively. (See <bold>Image</bold>.&#x000a0;Metabolic Pathway for Bilirubin in the Hepatocyte).&#x000a0;</p>
        <p>
<bold>Unconjugated Hyperbilirubinemia</bold>
</p>
        <p>Unconjugated (ie, indirect) hyperbilirubinemia (UHB) is the more common type and is either physiologic or pathologic. Physiologic jaundice accounts for 75% of neonatal hyperbilirubinemia and results from a physiologic alteration in neonatal bilirubin metabolism. Healthy adults have a total serum bilirubin (TSB) level of less than 1mg/dL. In neonates, normal TSB levels are comparatively higher, with age-dependant levels. Even healthy full-term newborns have an increased bilirubin load due to&#x000a0;higher red blood cell (RBC) mass and decreased RBC lifespan. Metabolic bilirubin clearance is also compromised due to impaired activity of uridine diphosphate glucuronosyltransferase (UGT), the enzyme needed for bilirubin conjugation. The activity level of the newborn UGT enzyme is approximately 1% that of an adult.<xref ref-type="bibr" rid="article-23803.r7">[7]</xref>&#x000a0;Moreover,&#x000a0;neonates also have increased enterohepatic circulation, further contributing to elevated TSB levels. Physiologic jaundice typically appears in full-term infants 24 hours after birth, peaks at around 48 to 96 hours, and resolves by 2 to 3 weeks.<xref ref-type="bibr" rid="article-23803.r2">[2]</xref>&#x000a0;Conversely, pathologic unconjugated hyperbilirubinemia occurs within&#x000a0;the first 24 hours after birth when the TSB level is &#x0003e;95% on age-specific bilirubin nomograms or increases&#x000a0;&#x02265;5 mg/dL/day or &#x0003e;0.2 mg/dL/hour.<xref ref-type="bibr" rid="article-23803.r8">[8]</xref>&#x000a0;Based on the mechanism of bilirubin elevation, the etiology of unconjugated hyperbilirubinemia can be subdivided into the following 3 categories: increased bilirubin production, decreased bilirubin clearance, and miscellaneous.</p>
        <p>
<bold>Increased Bilirubin Production</bold>
</p>
        <p>The production of bilirubin can increase secondary to immune-mediated hemolysis caused by blood group incompatibilities (eg, such as ABO and Rhesus (Rh) incompatibility) and nonimmune mediated hemolysis, which is caused by RBC membrane defects (eg, hereditary spherocytosis and elliptocytosis), RBC enzyme defects (eg, glucose-6-phosphate dehydrogenase [G6PD], pyruvate kinase deficiencies), sequestration-like cephalohematoma, subgaleal hemorrhage, intracranial hemorrhage, polycythemia, and sepsis. Exaggerated immune or nonimmune mediated hemolysis is the most common cause of pathologic hyperbilirubinemia.&#x000a0;Immune-mediated hemolysis occurs with blood group incompatibility as ABO/Rh incompatibility and&#x000a0;causes hemolytic disease&#x000a0;of the newborn (HDN).&#x000a0;In HDN&#x000a0;from&#x000a0;ABO incompatibility, preformed maternal anti-A and anti-B antibodies of the immunoglobulin G (IgG) subclass cross the placenta and cause hemolysis and UHB in newborns with blood types A, B, or AB.&#x000a0;Although the direct&#x000a0;antiglobulin test (DAT) aids diagnosis, the sensitivity and positive predictive value for severe UHB are low.<xref ref-type="bibr" rid="article-23803.r9">[9]</xref>&#x000a0;ABO incompatibility between mother and fetus exists in about 15% of pregnancies, but HDN&#x000a0;occurs in&#x000a0;only about 4% of newborns with ABO incompatibility.<xref ref-type="bibr" rid="article-23803.r10">[10]</xref>&#x000a0;</p>
        <p>In Rh incompatibility, an Rh-negative mother, exposed to Rh-positive RBCs&#x000a0;during a previous pregnancy, becomes sensitized and develops antibodies against Rh antigen. Initially, sensitization produces IgM antibodies that cannot cross the placenta. However, during subsequent pregnancies, IgG antibodies cross the placenta, causing RBC hemolysis in&#x000a0;a fetus with Rh-positive blood. The Rh antigen is very immunogenic, and the resultant HDN is usually severe, often leading to hydrops&#x000a0;fetalis or severe UHB in newborns. Prevention of neonatal UHB caused by immune-mediated hemolysis begins in pregnancy with the recognition of mothers at risk for developing Rh antibodies. The American College of Obstetricians and Gynecologists (ACOG)&#x000a0;recommends that all Rh-negative pregnant women receive anti-D immune globulin at 28 weeks gestation and again&#x000a0;after delivery if the infant is Rh-positive or the blood type is unknown.<xref ref-type="bibr" rid="article-23803.r11">[11]</xref></p>
        <p>Nonimmune causes of UHB include RBC enzyme defects, RBC membrane defects, hemoglobinopathies, sepsis, sequestration, and polycythemia. Glucose-6 phosphatase dehydrogenase (G6PD) deficiency is the most common RBC enzyme defect, transmitted as an X-linked recessive trait. G6PD protects RBCs against oxidative damage by generating NADPH (nicotinamide adenine dinucleotide phosphate hydrogenase) from NADP (nicotinamide adenine dinucleotide phosphate). When exposed to oxidant stressors like illness, certain medications, dyes, and foods&#x000a0;such as fava beans, G6PD deficient RBCs are hemolyzed, causing anemia and hyperbilirubinemia. More than 200 different mutations cause G6PD deficiency.<xref ref-type="bibr" rid="article-23803.r12">[12]</xref>&#x000a0;The clinical presentation differs depending on the variant, and some newborns may develop severe hyperbilirubinemia and bilirubin encephalopathy. Pyruvate kinase deficiency (PKD) is another&#x000a0;condition that causes hemolysis and may present as UHB in newborns.&#x000a0;PKD is an autosomal recessive (AR) disorder interfering with glycolysis and cellular energy production. In PKD, RBCs have shortened life spans,&#x000a0;resulting in hemolytic anemia and UHB.<xref ref-type="bibr" rid="article-23803.r13">[13]</xref></p>
        <p>Conditions causing UHB due to RBC membrane defects include hereditary spherocytosis (HS) and hereditary elliptocytosis (HE). HS (ie, Minkowski Chauffard disease) is the most common RBC membrane defect caused by RBC membrane protein mutations.<xref ref-type="bibr" rid="article-23803.r14">[14]</xref> Most cases are transmitted as an autosomal dominant (AD) trait and can present in the neonatal period with UHB.<xref ref-type="bibr" rid="article-23803.r15">[15]</xref>&#x000a0;Hereditary elliptocytosis is another type of RBC membrane defect caused by structural membrane protein&#x000a0;mutations in which elliptical-shaped RBCs are trapped in the spleen, leading to extravascular hemolysis and elevated TSB. HE is usually asymptomatic but&#x000a0;may cause UHB in the neonatal period.<xref ref-type="bibr" rid="article-23803.r16">[16]</xref>&#x000a0;</p>
        <p>Etiologies that cause RBC sequestration (eg, cephalohematoma, subgaleal hemorrhage, and intracranial hemorrhage) are also risk factors for neonatal UHB due to increased bilirubin load. Polycythemia is another&#x000a0;condition associated with an increased risk of UHB in newborns, associated with intrauterine growth restriction (IUGR), infants of diabetic mothers (IDM), large for gestational age (LGA) infants, maternal smoking, high altitude, twin to twin transfusions, and placental transfusion (eg, delayed cord clamping and umbilical cord milking). Studies&#x000a0;show that&#x000a0;delayed cord clamping reduces the incidence of postnatal anemia and leads to improved neurodevelopmental outcomes among term and preterm infants.<xref ref-type="bibr" rid="article-23803.r17">[17]</xref><xref ref-type="bibr" rid="article-23803.r18">[18]</xref>&#x000a0;Delayed cord clamping has gained popularity but may also increase the risk of hyperbilirubinemia.<xref ref-type="bibr" rid="article-23803.r19">[19]</xref><xref ref-type="bibr" rid="article-23803.r20">[20]</xref></p>
        <p>
<bold>Decreased&#x000a0;Bilirubin Clearance</bold>
</p>
        <p>Indirect hyperbilirubinemia due to decreased bilirubin clearance usually results from quantitative or qualitative defects in the uridine diphosphate glucuronosyltransferase (UGT) enzyme. Gilbert syndrome and Crigler&#x02013;Najjar syndrome type I and II are 3 disorders resulting from an abnormality of the UGT enzyme. Gilbert syndrome is the most common due to a mutation in the <italic toggle="yes">UGT1A1</italic> gene leading to decreased UGT production and subsequent unconjugated hyperbilirubinemia.<xref ref-type="bibr" rid="article-23803.r21">[21]</xref>&#x000a0;Gilbert syndrome typically presents as mild jaundice at times of physiologic stress in the absence of hemolysis or liver dysfunction. However, presentations during the neonatal period are rare and usually associated with G6PD deficiency.<xref ref-type="bibr" rid="article-23803.r22">[22]</xref><xref ref-type="bibr" rid="article-23803.r3">[3]</xref>&#x000a0;Crigler-Najjar syndrome type I is an AR disorder resulting from a complete absence of UGT activity. Affected patients present with&#x000a0;severe hyperbilirubinemia in the first few days of life, often leading to bilirubin encephalopathy. Patients with Crigler-Najjar syndrome type II retain some of the activity of UGT enzymes; therefore, their TSB levels are not as elevated as&#x000a0;in patients with the type I variant, and bilirubin encephalopathy rarely develops.<xref ref-type="bibr" rid="article-23803.r23">[23]</xref></p>
        <p>
<bold>Miscellaneous Causes</bold>
</p>
        <p>Other etiologies of UHG include congenital hypothyroidism, sulfa medications, ceftriaxone, penicillins, intestinal obstruction, pyloric stenosis, breast milk jaundice, and suboptimal intake with breastfeeding. Infants of mothers with diabetes are at higher risk of developing unconjugated hyperbilirubinemia. Jaundice secondary to breastfeeding and breast milk are 2 other common etiologies of UHB in newborns. Breastfeeding jaundice, known as suboptimal intake hyperbilirubinemia, occurs in the first week of life due to inadequate breast milk consumption, leading to dehydration and&#x000a0;occasionally hypernatremia.<xref ref-type="bibr" rid="article-23803.r7">[7]</xref>&#x000a0;Poor intake decreases intestinal motility and elimination of bilirubin in the stool. Conversely, breast milk jaundice occurs late in the first week after birth, peaks in the second week, and usually resolves by 2 weeks of age, though the condition may persist for up to 3 months. Breast milk jaundice is&#x000a0;rarely&#x000a0;pathologic and is associated with adequate intake and good weight gain.<xref ref-type="bibr" rid="article-23803.r24">[24]</xref>&#x000a0;Inhibition of the UGT enzyme by pregnanediol and the deconjugation of&#x000a0;conjugated bilirubin in the intestines by beta-glucuronidase present in breast milk is thought to be the primary underlying pathophysiology.<xref ref-type="bibr" rid="article-23803.r25">[25]</xref><xref ref-type="bibr" rid="article-23803.r26">[26]</xref></p>
        <p>Other miscellaneous causes of UHB include infants of mothers with diabetes (IDM), gastrointestinal obstruction, congenital hypothyroidism, and certain medications. IDM often have polycythemia,&#x000a0;with an increased incidence of jaundice.<xref ref-type="bibr" rid="article-23803.r27">[27]</xref>&#x000a0;UHB in congenital hypothyroidism is related to decreased bilirubin hepatic uptake, impaired UGT activity, and sluggish gut motility, while gastrointestinal obstruction promotes increased bilirubin recycling by augmenting enterohepatic circulation. When&#x000a0;prescribed in the neonatal period, certain medications may worsen UHB by displacing bilirubin from albumin, affecting albumin binding.<xref ref-type="bibr" rid="article-23803.r28">[28]</xref>&#x000a0;Sepsis can also predispose a newborn to UHB by causing oxidative damage to RBCs and increasing bilirubin load.<xref ref-type="bibr" rid="article-23803.r29">[29]</xref></p>
        <p>Additionally, most infants with clinical UHB have a combination of 2 or more predisposing contributing factors, including&#x000a0;prematurity, a history of jaundice requiring phototherapy in parents or siblings, Asian ethnicity, male gender, and exclusive breastfeeding.<xref ref-type="bibr" rid="article-23803.r2">[2]</xref>&#x000a0;Preterm infants&#x000a0;are at increased risk of bilirubin encephalopathy and kernicterus and require close monitoring, although there is insufficient data and a lack of&#x000a0;consensus guidelines on managing&#x000a0;UHB in preterm infants.<xref ref-type="bibr" rid="article-23803.r30">[30]</xref><xref ref-type="bibr" rid="article-23803.r31">[31]</xref>&#x000a0;Because of the increased risk of neurotoxicity, the TSB threshold for initiation of phototherapy is lower than for term infants. However, bilirubin is an antioxidant and may&#x000a0;have&#x000a0;a physiologic role in neonates.<xref ref-type="bibr" rid="article-23803.r32">[32]</xref><xref ref-type="bibr" rid="article-23803.r33">[33]</xref>&#x000a0;Keeping TSB levels low by aggressive treatment in preterm infants may&#x000a0;reduce this antioxidant level and potentially worsen retinopathy of prematurity. Moreover, reduced antioxidant status is also associated with&#x000a0;chronic lung disease and neurological injury. Therefore,&#x000a0;treating UHB in&#x000a0;premature neonates is&#x000a0;challenging&#x000a0;without evidence-based guidelines. The most recent clinical practice guidelines for managing hyperbilirubinemia of the American Academy of Pediatrics in 2022&#x000a0;included only infants &#x0003e;35 weeks of gestation.<xref ref-type="bibr" rid="article-23803.r34">[34]</xref><xref ref-type="bibr" rid="article-23803.r30">[30]</xref></p>
        <p>
<bold>Conjugated Hyperbilirubinemia</bold>
</p>
        <p>Conjugated hyperbilirubinemia (CHB), also referred to as neonatal cholestasis, is characterized by the elevation of serum conjugated (ie, direct) bilirubin (&#x0003e;1.0 mg/dL) due to impaired hepatobiliary function. Distinguishing CHB from UHB is critical because cholestatic neonatal jaundice is almost always pathologic and warrants&#x000a0;prompt evaluation and treatment.<xref ref-type="bibr" rid="article-23803.r35">[35]</xref>&#x000a0;The&#x000a0;causes of CHB are extensive and typically classified into the following categories:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Infection</bold>:<bold>&#x000a0;</bold>Congenital infections (eg, syphilis, toxoplasmosis, HIV, herpes virus, and rubella) should be included in the differential diagnosis of neonatal cholestasis, especially when stigmata of congenital infection, including growth restriction, coagulopathy, skin rash,&#x000a0;or thrombocytopenia, are present. Cytomegalovirus (CMV) is also a common congenital infection&#x000a0;with many manifestations. Most infected newborns are asymptomatic, but hepatomegaly and CHB may&#x000a0;indicate hepatic involvement.<xref ref-type="bibr" rid="article-23803.r36">[36]</xref>&#x000a0;Carefully reviewing maternal history, specific serologies, and viral culture results aid diagnosis. Urine and blood cultures are also a component of the diagnostic evaluation, as urinary tract infections and septicemia can cause CHB in neonates. Additionally, microcirculatory changes in the liver, a direct effect of bacterial products, and toxins released by bacteria are thought to be the possible mechanisms of cholestasis in patients with UTI.<xref ref-type="bibr" rid="article-23803.r37">[37]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Obstruction of biliary flow</bold>: Conditions with this underlying pathophysiology include&#x000a0;biliary atresia, choledochal cysts, neonatal sclerosing cholangitis, and neonatal cholelithiasis. Biliary atresia (BA) is the most common cause of conjugated hyperbilirubinemia in infants, with an incidence that varies by geographic location.<xref ref-type="bibr" rid="article-23803.r38">[38]</xref>&#x000a0;Taiwan, the region with the highest incidence, has a reported frequency of 1 in 6000 live births. In the United States, the&#x000a0;incidence is about 1 in 12,000 live births.<xref ref-type="bibr" rid="article-23803.r39">[39]</xref>&#x000a0;The etiology of BA is not well understood, but genetic factors, viral infections, toxins, chronic inflammation, and autoimmune injury to bile ducts seem to play a role in&#x000a0;the pathogenesis. The disease involves both intra-hepatic&#x000a0;and extrahepatic bile ducts and classically presents around 2 to 4 weeks after birth with pale stools and jaundice. The initial ultrasound examination may reveal an absent gallbladder and the classic "triangular cord" sign, a ductal remnant of the extrahepatic bile duct.<xref ref-type="bibr" rid="article-23803.r40">[40]</xref>&#x000a0;Early diagnosis is critical to maximizing the response to the Kasai operation (ie, hepatic portoenterostomy).<xref ref-type="bibr" rid="article-23803.r41">[41]</xref>&#x000a0;If surgery is delayed&#x000a0;until after 90 days of life, &#x0003c;25% of patients are&#x000a0;likely to respond, compared to surgery performed within 60 days when &#x0003e;70% of patients will establish adequate bile flow.<xref ref-type="bibr" rid="article-23803.r42">[42]</xref>
</p>
            <p>Choledochal cysts can also cause biliary flow obstruction. The intrahepatic&#x000a0;and extrahepatic bile ducts are dilated when choledochal cysts are present, and ultrasonography can detect cysts with normal or dilated intrahepatic bile ducts as opposed to the sclerosed ducts of biliary atresia. However, cystic biliary atresia may resemble choledochal cysts.<xref ref-type="bibr" rid="article-23803.r43">[43]</xref>&#x000a0;Neonatal sclerosing cholangitis (NSC) is a rare form of cholangiopathy that presents in infancy with CHB, hepatosplenomegaly, pale stools, and high serum gamma-glutamyltransferase activity (GGT).<xref ref-type="bibr" rid="article-23803.r44">[44]</xref>&#x000a0;Neonatal cholelithiasis is&#x000a0;another rare entity that causes significant direct hyperbilirubinemia.<xref ref-type="bibr" rid="article-23803.r45">[45]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Genetic</bold>:&#x000a0;There are several genetic etiologies (eg, Alagille syndrome, alpha-1 anti-trypsin deficiency, galactosemia, fructosemia, Tyrosinemia type 1, cystic fibrosis, progressive familial intrahepatic cholestasis [PFIC],&#x000a0;Aagenaes syndrome, Dubin-Johnson syndrome, bile acid synthesis disorders [BSAD]) that commonly result in CHB. Alagille syndrome (ALGS) is an AD disorder caused by mutations in the&#x000a0;<italic toggle="yes">JAG1</italic>&#x000a0;or&#x000a0;<italic toggle="yes">NOTCH2</italic>&#x000a0;genes, leading to a lack of interlobular bile ducts.<xref ref-type="bibr" rid="article-23803.r46">[46]</xref>&#x000a0;With an incidence&#x000a0;of 1 in 30,000 live births, ALGS is the most common cause of familial intrahepatic cholestasis, though CHB in patients with ALGS may resolve with age.<xref ref-type="bibr" rid="article-23803.r47">[47]</xref><xref ref-type="bibr" rid="article-23803.r35">[35]</xref>&#x000a0;Characteristic clinical features include butterfly vertebrae, congenital heart defects (eg, peripheral pulmonic stenosis), kidney involvement, dysmorphic features (eg, broad forehead and a small pointed chin), and posterior embryotoxon of the eye. Gamma-glutamyl transferase (GGT) levels are elevated, often up to 20 times the standard value. Occasionally, patients with cystic fibrosis (CF) present with cholestasis because of abnormal bile that plugs the bile ducts.<xref ref-type="bibr" rid="article-23803.r48">[48]</xref>&#x000a0;In developing nations where newborn screening with immunoreactive trypsinogen is unavailable, neonatal cholestasis may be the first clue to&#x000a0;diagnosing CF.&#x000a0;
</p>
            <p>Alpha-1-antitrypsin deficiency&#x000a0;is the most common&#x000a0;genetic cause of cholestasis and&#x000a0;can mimic biliary atresia in early infancy. Accumulation of anti-trypsin polymers in the hepatocyte&#x000a0;endoplasmic reticulum of a patient with the <italic toggle="yes">PIZZ</italic> genotype leads to apoptosis of hepatocytes, ultimately resulting in cholestasis and cirrhosis later in childhood.<xref ref-type="bibr" rid="article-23803.r49">[49]</xref>&#x000a0;As with ALGS, cholestasis may improve with age. Galactosemia, fructosemia, and tyrosinemia type 1 are a few of the inborn errors of metabolism known to cause cholestasis in neonates. Newborns with galactosemia can present with cholestatic jaundice, cataracts, hepatomegaly, failure to thrive, renal tubular acidosis, and&#x000a0;<italic toggle="yes">Escherichia coli</italic>&#x000a0;sepsis after&#x000a0;ingesting galactose from milk.<xref ref-type="bibr" rid="article-23803.r50">[50]</xref>&#x000a0;Galactose-1-phosphate uridyl transferase (GALT) deficiency leads to the accumulation of toxic galactose metabolites in multiple organs. The presence of urine-reducing substances suggests galactosemia, but GALT activity in the liver or erythrocytes confirms the diagnosis. Neonatal cholestasis&#x000a0;is a presenting feature in hereditary&#x000a0;tyrosinemia type 1, another AR disorder caused by a deficiency of the enzyme fumarylacetoacetate hydroxylase. Other&#x000a0;characteristics of this disorder include renal Fanconi syndrome, hepatomegaly, coagulation abnormality, and the risk of hepatocellular carcinoma in untreated older patients.<xref ref-type="bibr" rid="article-23803.r51">[51]</xref></p>
            <p>Progressive familial intrahepatic cholestasis (PFIC) is a heterogeneous group of 3 genetic disorders involving canalicular hepatobiliary transport that presents with cholestasis.<xref ref-type="bibr" rid="article-23803.r52">[52]</xref>&#x000a0;Types 1 and 2 usually manifest in the neonatal period, while type 3 presents later in infancy. Affected patients with PFIC frequently develop cirrhosis and end-stage liver disease during childhood. In diagnostic studies, the GGT level is&#x000a0;within the normal range in types 1 and 2 and elevated in type 3 patients. PFIC type 1 is caused by a mutation in the <italic toggle="yes">ATP8B1</italic> gene, which encodes the FIC1 protein, whereas PFIC type 2 is caused by a mutation in the <italic toggle="yes">ABCB11</italic> gene, which encodes for the bile salt excretory protein (BSEP). PFIC type 3 is caused by a mutation in the <italic toggle="yes">ABCB4</italic> gene, which encodes for the multi-drug resistant-3 protein (MDR3).<xref ref-type="bibr" rid="article-23803.r53">[53]</xref>&#x000a0;Aagenaes syndrome, also known as lymphedema cholestasis syndrome (LCS), is another idiopathic familial intrahepatic cholestasis syndrome characterized by neonatal cholestasis and lymphedema in the lower extremities. Aagenaes syndrome is transmitted as an autosomal recessive (AR) trait usually seen in individuals of Norwegian descent.<xref ref-type="bibr" rid="article-23803.r54">[54]</xref>&#x000a0;Dubin-Johnson syndrome (DJS) is a rare AR disorder caused by a mutation in the <italic toggle="yes">ABCC2</italic> gene, which codes for a non-biliary ion transporter in the liver. A unique feature of DJS is a black-colored&#x000a0;liver and the excretion of coproporphyrin 1 in urine.<xref ref-type="bibr" rid="article-23803.r55">[55]</xref>&#x000a0;Bile acid synthesis disorder (BASD) results from a deficiency of an enzyme involved in synthesizing bile acids from cholesterol. BASDs are an uncommon cause of cholestasis, but many are curable with medical therapy.</p>
          </list-item>
          <list-item>
            <p><bold>Miscellaneous</bold>:&#x000a0;Other conditions that may cause CHD include idiopathic neonatal hepatitis, parenteral nutrition-induced cholestasis, gestational alloimmune liver disease, neonatal hemochromatosis, and hypotension. Parenteral nutrition-associated cholestasis (PNAC) is a significant iatrogenic cause of cholestasis in preterm infants managed with parenteral nutrition (PN). PNAC&#x000a0;is present in about 20% of neonates&#x000a0;receiving PN for 2 weeks or longer.<xref ref-type="bibr" rid="article-23803.r56">[56]</xref>&#x000a0;Duration of PN use and intestinal failure are 2 independent risk factors for PNAC. Though the mechanism is not entirely clear, likely being multifactorial, abnormal bile salt metabolism due to prematurity and the harmful effects of PN components are thought to be the main culprits.<xref ref-type="bibr" rid="article-23803.r57">[57]</xref>&#x000a0;Other factors, including sepsis and necrotizing enterocolitis, can also potentiate liver injury.<xref ref-type="bibr" rid="article-23803.r58">[58]</xref>&#x000a0;Gestational alloimmune liver disease (GALD), which causes almost all cases of neonatal hemochromatosis, is a fulminant alloimmune disorder and results from intrahepatic and extrahepatic iron deposition, leading to liver failure.<xref ref-type="bibr" rid="article-23803.r59">[59]</xref>&#x000a0;In GALD, maternal IgG immunoglobulin against fetal hepatocytes crosses the placenta, causing complement-mediated damage to fetal hepatocytes. Characteristic features involve signs of liver failure, including hypoglycemia, coagulopathy, hypoalbuminemia, cholestatic jaundice, edema, and elevated liver enzymes. GALD has a risk of recurrence in subsequent pregnancies of approximately 90% and can result in fetal or neonatal death.<xref ref-type="bibr" rid="article-23803.r60">[60]</xref>&#x000a0;The term idiopathic neonatal hepatitis is used when the etiology of neonatal cholestasis cannot be ascertained after an extensive diagnostic evaluation. Newer diagnostic tools&#x000a0;enable more precise diagnoses, with fewer cases of neonatal cholestasis now classified as "idiopathic."<xref ref-type="bibr" rid="article-23803.r42">[42]</xref>&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23803.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Unconjugated hyperbilirubinemia is&#x000a0;frequently encountered in the neonatal period. About 80% of term and preterm newborns will present with clinical jaundice with a TSB &#x0003e;5 mg/dL.<xref ref-type="bibr" rid="article-23803.r2">[2]</xref><xref ref-type="bibr" rid="article-23803.r61">[61]</xref>&#x000a0;However, only approximately 10% of&#x000a0;neonates require phototherapy.<xref ref-type="bibr" rid="article-23803.r62">[62]</xref>&#x000a0;Physiologic jaundice is the most frequent cause of clinical jaundice after the first day of life, estimated to account for 50% of cases.<xref ref-type="bibr" rid="article-23803.r63">[63]</xref>&#x000a0;Approximately 15%&#x000a0;of breastfed infants will develop physiologic UHB lasting &#x0003e;3 weeks.<xref ref-type="bibr" rid="article-23803.r64">[64]</xref></p>
        <p>Only a minority of jaundiced newborns have&#x000a0;pathologic hyperbilirubinemia. Severe hyperbilirubinemia, commonly defined as a TSB&#x0003e;25 mg/dL,&#x000a0;occurs in approximately 1 out of 2500 live births.&#x000a0;Among these, ABO incompatibility, followed by G6PD deficiency, is the most frequently identified cause.<xref ref-type="bibr" rid="article-23803.r65">[65]</xref>&#x000a0;Newborns with Southeast and East Asian ancestry have higher recorded TSB levels than Black or White infants.<xref ref-type="bibr" rid="article-23803.r66">[66]</xref><xref ref-type="bibr" rid="article-23803.r67">[67]</xref>&#x000a0;Neonatal jaundice also appears more common in infants&#x000a0;living at high altitudes and around the Mediterranean Sea, especially in Greece.<xref ref-type="bibr" rid="article-23803.r68">[68]</xref><xref ref-type="bibr" rid="article-23803.r69">[69]</xref>&#x000a0;</p>
        <p>Acute&#x000a0;bilirubin encephalopathy occurs&#x000a0;at a rate of approximately 1 in 10,000 live births,&#x000a0;and&#x000a0;the incidence of chronic bilirubin encephalopathy is comparitively lower, estimated at 1 in 50,000 to 100,000 live births.<xref ref-type="bibr" rid="article-23803.r70">[70]</xref>&#x000a0;However, developing nations report higher rates of kernicterus, a permanent neurologic condition.<xref ref-type="bibr" rid="article-23803.r71">[71]</xref></p>
        <p>Conjugated hyperbilirubinemia is much less common&#x000a0;than UHB, with an incidence of around 1 in 2500 term infants.<xref ref-type="bibr" rid="article-23803.r72">[72]</xref>&#x000a0;The most&#x000a0;frequently identified cause of cholestatic jaundice in the neonatal period is biliary atresia, accounting for an estimated 25%&#x000a0;to 40% of all cases, followed by infections and PN-induced cholestasis.<xref ref-type="bibr" rid="article-23803.r35">[35]</xref><xref ref-type="bibr" rid="article-23803.r73">[73]</xref>&#x000a0;Approximately 60% to 70% of patients with BA will require liver transplantation in childhood, remaining the most common indication for a pediatric liver transplant.<xref ref-type="bibr" rid="article-23803.r74">[74]</xref></p>
      </sec>
      <sec id="article-23803.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Bilirubin is produced from the catabolism of heme, a breakdown product of hemoglobin, in the reticuloendothelial system (RES). First, heme&#x000a0;is converted to biliverdin, releasing iron and carbon monoxide&#x000a0;via the action of the enzyme heme oxygenase.<xref ref-type="bibr" rid="article-23803.r75">[75]</xref>&#x000a0;Biliverdin&#x000a0;is then converted to bilirubin by the enzyme biliverdin reductase. This hydrophobic unconjugated bilirubin binds to albumen, is transported to the liver,&#x000a0;and&#x000a0;is conjugated with glucuronic acid in the smooth endoplasmic reticulum by the enzyme uridine diphosphate-glucuronosyltransferase (UGT). Conjugated bilirubin is water soluble and is excreted in bile, passed into the gastrointestinal (GI) tract, and eliminated in feces. Some conjugated bilirubin is deconjugated in the GI tract by beta-glucuronidase and reabsorbed through the enterohepatic circulation.<xref ref-type="bibr" rid="article-23803.r76">[76]</xref></p>
        <p>Newborn infants have higher TSB levels than adults&#x000a0;due to higher hemoglobin levels at birth, a shorter RBC life span, and limited conjugating ability of the&#x000a0;neonatal liver.<xref ref-type="bibr" rid="article-23803.r77">[77]</xref>&#x000a0;Healthy, full-term newborns&#x000a0;typically have peak serum bilirubin concentrations of 5 to 6 mg/dL compared to adult levels of &#x0003c;1 mg/dL. Pathologic jaundice in neonates is related to increased production of bilirubin in the RES, impaired hepatic uptake, deficient conjugation of bilirubin, and enhanced enterohepatic circulation of bilirubin.<xref ref-type="bibr" rid="article-23803.r75">[75]</xref>&#x000a0;</p>
        <p>In severe hyperbilirubinemia, unbound, unconjugated bilirubin crosses the blood-brain barrier and binds to the brainstem, hippocampus, cerebellum, globus pallidus, and subthalamic nuclei.<xref ref-type="bibr" rid="article-23803.r2">[2]</xref>&#x000a0;At the cellular level, bilirubin inhibits certain mitochondrial enzymes,&#x000a0;interferes with DNA and protein synthesis, induces breaks in DNA strands, and hampers phosphorylation.<xref ref-type="bibr" rid="article-23803.r78">[78]</xref>&#x000a0;Bilirubin also impairs tyrosine uptake and alters the normal functioning of N-methyl-D-aspartate&#x02013;receptor ion channels.<xref ref-type="bibr" rid="article-23803.r79">[79]</xref><xref ref-type="bibr" rid="article-23803.r80">[80]</xref>&#x000a0;These mechanisms are implicated in the pathogenesis of bilirubin toxicity that clinically manifests as&#x000a0;bilirubin-induced neurologic dysfunction (BIND) and bilirubin encephalopathy. The&#x000a0;duration of exposure to bilirubin and the amount of bilirubin in the brain determines the severity of brain damage. However, the TSB level does not correlate well with bilirubin toxicity without hemolysis.<xref ref-type="bibr" rid="article-23803.r75">[75]</xref>&#x000a0;Preterm infants are more vulnerable to the toxic effects of free unconjugated bilirubin. This may be related to comparatively lower serum albumin levels, CNS immaturity, and comorbidities&#x000a0;such as&#x000a0;intraventricular hemorrhage, periventricular leukomalacia, sepsis, necrotizing enterocolitis, and bronchopulmonary dysplasia.<xref ref-type="bibr" rid="article-23803.r71">[71]</xref></p>
        <p>Conjugated hyperbilirubinemia results from abnormalities in the uptake, metabolism, transport, and excretion of bile salts and bilirubin, which&#x000a0;increases bile acid in the liver, promoting the proliferation of bile ducts and fibrosis.<xref ref-type="bibr" rid="article-23803.r81">[81]</xref> Bile&#x000a0;acid is also responsible for the inflammation and apoptosis of hepatocytes, culminating in hepatocellular injury and cirrhosis.<xref ref-type="bibr" rid="article-23803.r82">[82]</xref>&#x000a0;Deficient bile secretion in cholestasis results in malabsorption of fat and fat-soluble vitamins A, D, E, and K and may lead to&#x000a0;inadequate nutrition and weight gain.<xref ref-type="bibr" rid="article-23803.r83">[83]</xref></p>
      </sec>
      <sec id="article-23803.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Kernicterus is derived from the&#x000a0;German word <italic toggle="yes">kern</italic>, meaning core, referring to the basal ganglia. Yellow&#x000a0;staining of deeper brain nuclei is seen on autopsy specimens of infants with severe unconjugated hyperbilirubinemia. Histopathologic findings include nuclei that have undergone pyknosis, cytoplasm vacuolation, and fading of the Nissl substance in neurons.<xref ref-type="bibr" rid="article-23803.r84">[84]</xref>&#x000a0;</p>
        <p>A liver&#x000a0;biopsy is&#x000a0;usually&#x000a0;necessary for a&#x000a0;definitive diagnosis of cholestasis as it helps to differentiate biliary atresia from idiopathic neonatal hepatitis. Histopathologic features of BA include the expansion of the hepatic portal tracts with edema, fibrodysplasia, bile ductular proliferation, and the presence of bile plugs in the ductal lumen. Multinucleate giant cells and hemopoiesis are also findings noted on histopathologic examinations of cholestatic liver samples.<xref ref-type="bibr" rid="article-23803.r85">[85]</xref>&#x000a0;Although not diagnostic of any particular disorder, the prominence of hepatic erythropoiesis is seen more frequently in cholestasis of infectious etiology. Pathognomonic histologic findings of other cholestatic&#x000a0;conditions include&#x000a0;periodic acid-Schiff (PAS) positive granules noted with alpha-1 antitrypsin deficiency, a paucity of bile ducts associated with Alagille syndrome, and periductal necrosis and inflammation seen in sclerosing cholangitis.<xref ref-type="bibr" rid="article-23803.r86">[86]</xref>&#x000a0;Among familial causes of cholestasis, canalicular cholestasis with a marked absence of ductular proliferation and isolated periportal biliary metaplasia of hepatocytes is commonly seen in patients with PFIC type 1. Though the histopathology of PFIC type 2 is similar, the altered liver architecture and extensive lobular and portal fibrosis with inflammation occur more frequently.<xref ref-type="bibr" rid="article-23803.r53">[53]</xref></p>
      </sec>
      <sec id="article-23803.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The evaluation of the neonate with jaundice&#x000a0;begins with a detailed history, including pregnancy complications, family history, delivery, the onset of associated symptoms, feeding adequacy, and maternal serologies.&#x000a0;Stool and urine color may provide a clue about the type of jaundice. Minor risk factors are serum bilirubin in the high-intermediate range, macrosomic infants of diabetic mothers, polycythemia, male gender, and maternal age older than 25.<xref ref-type="bibr" rid="article-23803.r8">[8]</xref>&#x000a0;The American Academy of Pediatrics (AAP) recommends universal visual screening of all newborns for jaundice every 12 hours from the time of birth until the infant is discharged home. Furthermore, clinicians should identify risk factors for severe hyperbilirubinemia.<xref ref-type="bibr" rid="article-23803.r8">[8]</xref>&#x000a0;Major risk factors in&#x000a0;newborns &#x0003e;35 weeks gestation include:<xref ref-type="bibr" rid="article-23803.r8">[8]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>A bilirubin level in the high-risk zone before hospital discharge</p>
          </list-item>
          <list-item>
            <p>Jaundice in the first 24 hours after birth</p>
          </list-item>
          <list-item>
            <p>Maternal-fetal blood group incompatibility</p>
          </list-item>
          <list-item>
            <p>Gestational age &#x0003c;36 weeks&#x000a0;<xref ref-type="bibr" rid="article-23803.r87">[87]</xref></p>
          </list-item>
          <list-item>
            <p>History of phototherapy in an immediate family member</p>
          </list-item>
          <list-item>
            <p>A cephalhematoma or significant bruising after delivery</p>
          </list-item>
          <list-item>
            <p>Exclusive breastfeeding</p>
          </list-item>
          <list-item>
            <p>Asian descent</p>
          </list-item>
        </list>
        <p>To assess for jaundice, newborns should ideally be examined in daylight. However, clinical assessment&#x000a0;is unreliable, especially if a newborn has received phototherapy or has dark skin.<xref ref-type="bibr" rid="article-23803.r88">[88]</xref>&#x000a0;Therefore, clinically significant jaundice should always be confirmed with a TSB or transcutaneous bilirubin (TcB). A focused&#x000a0;physical examination may identify the cause of pathologic jaundice.&#x000a0;Signs include pallor, petechiae, cephalohematoma, extensive bruising, hepatosplenomegaly, weight loss, and dehydration. All infants with jaundice should be assessed for clinical features of bilirubin encephalopathy, including poor feeding, lethargy, altered sleep, abnormal tone, and seizures.&#x000a0;However,&#x000a0;up to 15% of neonates with kernicterus are clinically asymptomatic in the newborn period.<xref ref-type="bibr" rid="article-23803.r75">[75]</xref>&#x000a0;Infants with signs and symptoms suggesting&#x000a0;neonatal cholestasis often have multisystem involvement, which may guide diagnostic investigations.</p>
      </sec>
      <sec id="article-23803.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Diagnosis Studies in Unconjugated Hyperbilirubinemia</bold>
</p>
        <p>The AAP recommends an infant's bilirubin levels should be assessed between 24 and 48 hours after birth. If an infant leaves the hospital prior to this time frame, a bilirubin level should be measured before discharge home.<bold>&#x000a0;</bold>Bilirubin levels are initially evaluated with a transcutaneous measurement device or blood samples for total serum bilirubin.<xref ref-type="bibr" rid="article-23803.r89">[89]</xref> Transcutaneous estimation of bilirubin can be used as a screening test for hyperbilirubinemia to reduce the frequency of blood tests, but the utility is limited in infants with dark skin and following phototherapy use.<xref ref-type="bibr" rid="article-23803.r90">[90]</xref><xref ref-type="bibr" rid="article-23803.r91">[91]</xref>&#x000a0;The serum level should be measured when the transcutaneous bilirubin (TcB) level exceeds the 95th percentile on the transcutaneous nomogram or 75% of the TSB&#x000a0;threshold for phototherapy. Another limitation of&#x000a0;the TcB is the inability to detect the direct fraction of bilirubin required for diagnosing neonatal cholestasis.</p>
        <p>Recommended studies to identify a hemolytic disease etiology of unconjugated hyperbilirubinemia include maternal and neonatal blood types,&#x000a0;a direct antibody&#x000a0;test (DAT), complete blood cell (CBC), reticulocyte count, blood smear, and G6PD testing. Serum albumin,&#x000a0;considered a surrogate marker for free bilirubin, should be checked, especially if the TSB level approaches the level where exchange transfusion is indicated. Free bilirubin is the fraction responsible for bilirubin-induced toxicity.<xref ref-type="bibr" rid="article-23803.r92">[92]</xref>&#x000a0;The bilirubin-albumin ratio (B/A) ratio is an additional tool that may predict the risk of kernicterus and serve as a guide when considering the escalation of care and exchange transfusion.</p>
        <p>Radiographic imaging is usually not required for most cases of UCH. Brain magnetic resonance imaging (MRI) findings have high sensitivity for bilirubin encephalopathy, with posteromedial borders of the globus pallidus being the most sensitive region for detecting signal changes. Infants with bilirubin encephalopathy demonstrate hyperintense signals on&#x000a0;T1-weighted sequences in the acute stage that eventually become hyperintense on T2-weighted sequences as the&#x000a0;condition evolves. Magnetic resonance spectroscopy (MRS) shows increased levels of glutamate and decreased levels of N-acetyl-aspartate and choline.<xref ref-type="bibr" rid="article-23803.r93">[93]</xref>&#x000a0;However, the absence of these findings does not exclude the risk of chronic bilirubin encephalopathy.</p>
        <p>
<bold>Diagnostic Studies in Conjugated Hyperbilirubinemia</bold>
</p>
        <p>Serum aminotransferases&#x000a0;may provide&#x000a0;evidence of hepatocellular injury in patients with conjugated hyperbilirubinemia. Alkaline phosphatase and elevated GGT levels&#x000a0;may indicate&#x000a0;an obstruction in biliary channels. The prothrombin time (PT), the international normalized ratio (INR), and serum albumin evaluate hepatic synthesis and function. Additional tests like TORCH titers for in-utero infections, urine cultures, viral cultures, serologic titers, newborn screening, tests for inborn errors of metabolism, alpha-1 antitrypsin&#x000a0;phenotype, and genetic&#x000a0;profiles may be&#x000a0;diagnostic.</p>
        <p>Radiology&#x000a0;may be necessary&#x000a0;to evaluate neonatal cholestasis. Hepatic ultrasonography&#x000a0;can identify sludging in the biliary tree, gallstones, inspissated bile, and&#x000a0;choledochal cysts. A&#x000a0;triangular cord sign on hepatic ultrasound has high sensitivity and almost 100% specificity for biliary atresia.<xref ref-type="bibr" rid="article-23803.r81">[81]</xref>&#x000a0;Hepatobiliary scintigraphy is another modality utilized to evaluate neonatal cholestasis. Decreased excretion of the tracer 24 hours after introduction suggests obstruction and further differentiates obstructive and nonobstructive causes of cholestasis.<xref ref-type="bibr" rid="article-23803.r94">[94]</xref>&#x000a0;Prior treatment with phenobarbital&#x000a0;improves the sensitivity of hepatobiliary scintigraphy. However, a liver biopsy&#x000a0;is the gold standard&#x000a0;for diagnosing neonatal cholestasis. Histopathologic interpretation by an experienced pathologist will identify the correct diagnosis in 90% to 95% of cases and may prevent unnecessary interventions in patients with intrahepatic cholestasis.<xref ref-type="bibr" rid="article-23803.r95">[95]</xref></p>
      </sec>
      <sec id="article-23803.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>Treatment of Unconjugated Hyperbilirubinemia</bold>
</p>
        <p>Phototherapy and exchange transfusion are the mainstays of treatment for&#x000a0;newborns with unconjugated hyperbilirubinemia. Other treatment modalities may be utilized based on patient response to these therapies. The approach to treatment is determined by the neurotoxicity risk factors present, neonatal gestational age, and hour-specific TSB.<xref ref-type="bibr" rid="article-23803.r8">[8]</xref></p>
        <p>
<bold>Phototherapy</bold>
</p>
        <p>Phototherapy (PT) remains the first-line treatment for managing pathologic unconjugated hyperbilirubinemia. PT&#x000a0;reduces TSB to safe levels and decreases the risk of bilirubin toxicity and the need for exchange transfusion. The TSB level at which PT is indicated is determined based on the risk factors for neurotoxicity present, the infant's gestational age, and hour-specific TSB.<xref ref-type="bibr" rid="article-23803.r34">[34]</xref><xref ref-type="bibr" rid="article-23803.r8">[8]</xref>&#x000a0;Risk factors for neurotoxicity that lower the TSB threshold to initiate PT include:<xref ref-type="bibr" rid="article-23803.r34">[34]</xref><xref ref-type="bibr" rid="article-23803.r8">[8]</xref>&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Neonatal gestational age &#x0003c;38 weeks</p>
          </list-item>
          <list-item>
            <p>Serum albumin &#x0003c;3.0 g/dL</p>
          </list-item>
          <list-item>
            <p>Positive DAT or diagnosis of G6PD deficiency or other hemolytic diseases</p>
          </list-item>
          <list-item>
            <p>Sepsis</p>
          </list-item>
          <list-item>
            <p>Significant clinical deterioration in the&#x000a0;preceding&#x000a0;24 hours</p>
          </list-item>
        </list>
        <p>However, for premature infants, few standardized guidelines exist, and most hospitals compile&#x000a0;their own protocols for phototherapy and exchange transfusion in preterm infants based on birth weight and gestational age.<xref ref-type="bibr" rid="article-23803.r31">[31]</xref>&#x000a0;The efficacy of phototherapy depends on the dose and wavelength of light used, as well as the infant's exposed surface area. Increasing the dose of PT can be achieved by placing phototherapy units at a minimum safe distance from the infant and increasing the number of units used.</p>
        <p>Bilirubin optimally absorbs light in the blue-green range (ie, 460-490 nm). The underlying mechanism of PT involves inducing photoisomerization and converting bilirubin into lumirubin, which is&#x000a0;readily excreted into bile and urine.<xref ref-type="bibr" rid="article-23803.r96">[96]</xref>&#x000a0;During phototherapy, the neonate's maximum body surface area should be exposed to the light source while keeping the eyes covered to avoid retinal injury, and interruptions should be minimized. The maintenance of hydration is necessary to ensure&#x000a0;adequate urine output, as most bilirubin is excreted in the urine as lumirubin, a structural isomer of bilirubin formed during phototherapy. Therefore, breastfeeding support should be offered to all nursing mothers as early initiation of breastfeeding and frequent, on-demand feeding decreases the likelihood of dehydration. Although supplemental oral water and dextrose water are not recommended, supplemental pumped breastmilk or infant formula can be considered&#x000a0;for feeding issues, including infants with ineffective sucking or latching or inadequate maternal milk production.<xref ref-type="bibr" rid="article-23803.r34">[34]</xref>&#x000a0;</p>
        <p>After phototherapy is discontinued, there may be an increase in the total serum bilirubin level, known as the <italic toggle="yes">rebound bilirubin</italic>. This level is usually lower than the pretreatment level and rarely&#x000a0;requires reinitiation of phototherapy.<xref ref-type="bibr" rid="article-23803.r97">[97]</xref>&#x000a0;PT&#x000a0;is considered safe, but recent evidence&#x000a0;suggests a possible association with long-term&#x000a0;sequelae, including a&#x000a0;small risk of epilepsy. However, no studies have proven causation.<xref ref-type="bibr" rid="article-23803.r98">[98]</xref>&#x000a0;A few studies also have reported a possible&#x000a0;association between&#x000a0;solid organ tumors and nonlymphocytic leukemias&#x000a0;and children treated with phototherapy.<xref ref-type="bibr" rid="article-23803.r99">[99]</xref><xref ref-type="bibr" rid="article-23803.r100">[100]</xref>&#x000a0;Adverse effects of PT include rashes, dehydration, hypocalcemia, retinal damage, hemolysis due to oxidative damage, delay in&#x000a0;patent ductus arteriosis closure in preterm infants, and allergic reactions.<xref ref-type="bibr" rid="article-23803.r101">[101]</xref>&#x000a0;Bronze baby syndrome is&#x000a0;a&#x000a0;self-limited condition associated with elevated levels of conjugated bilirubin that rarely occurs with PT, resulting in irregular, bronze-gray pigmentation&#x000a0;of&#x000a0;the skin, mucous membranes, and urine. The phenomenon's mechanism is&#x000a0;unclear but appears to be related&#x000a0;to the accumulation of bilirubin and biliverdin photoisomers. Bronze baby syndrome usually resolves within a few days of discontinuing phototherapy; however, the prognosis depends upon the underlying cause of the conjugated hyperbilirubinemia.<xref ref-type="bibr" rid="article-23803.r102">[102]</xref><xref ref-type="bibr" rid="article-23803.r103">[103]</xref></p>
        <p>
<bold>Exchange Transfusion</bold>
</p>
        <p>In 1947, exchange transfusion (ET) was the first successful treatment for jaundice.<xref ref-type="bibr" rid="article-23803.r104">[104]</xref>&#x000a0;Now, ET is the second-line treatment for severe unconjugated hyperbilirubinemia since phototherapy was developed in the 1950s.<xref ref-type="bibr" rid="article-23803.r105">[105]</xref><xref ref-type="bibr" rid="article-23803.r106">[106]</xref>&#x000a0;Indications for this therapy include neonatal failure to respond to PT or a TSB level at the exchange transfusion threshold. The threshold to initiate exchange transfusion is calculated based on several factors, including the TSB level and rate of rise, neonatal age (ie, hours or days since birth), and risk factors for neurologic complications.<xref ref-type="bibr" rid="article-23803.r34">[34]</xref> ET rapidly removes bilirubin and hemolysis-causing antibodies from the infant's circulation. A double-volume exchange blood transfusion (160-180 ml/kg) is performed, replacing aliquots of the neonate's blood with crossed-matched donor blood. Since most of the total body bilirubin&#x000a0;is extravascular, the TSB level immediately following ET is approximately 60% of the pre-exchange level, but that later increases to 70% to 80% of the pretreatment level as a result of equilibrium. During ET, the neonate's vital signs should be monitored closely. Following the procedure, TSB, CBC, serum calcium, glucose, and electrolytes should be rechecked due to potential complications, including electrolyte abnormalities (eg, hypocalcemia and hyperkalemia), cardiac arrhythmias, thrombocytopenia, blood-borne infections, portal vein thrombosis, graft versus host disease, and necrotizing enterocolitis (NEC).<xref ref-type="bibr" rid="article-23803.r107">[107]</xref><xref ref-type="bibr" rid="article-23803.r108">[108]</xref>&#x000a0;Phototherapy should resume after exchange transfusion until the bilirubin reaches a level where PT can be safely discontinued.&#x000a0;</p>
        <p>
<bold>Intravenous Immunoglobulin</bold>
</p>
        <p>Intravenous immunoglobulin (IVIG) is used when immune-mediated hemolysis is the cause of unconjugated hyperbilirubinemia, which prevents RBC hemolysis by coating Fc receptors on RBCs.The AAP recommends IVIG infusion in immune-mediated hemolysis if TSB remains within 2 to 3 mg/dL of the exchange threshold&#x000a0;despite intensive phototherapy.<xref ref-type="bibr" rid="article-23803.r109">[109]</xref><xref ref-type="bibr" rid="article-23803.r110">[110]</xref>&#x000a0;However, the evidence that IVIG reduces the need for ET is&#x000a0;unclear. Nonetheless, IVIG is often used in clinical practice to manage severe unconjugated hyperbilirubinemia.</p>
        <p>
<bold>Treatment of Conjugated Hyperbilirubinemia</bold>
</p>
        <p>Treatment of conjugated hyperbilirubinemia is tailored to the specific etiology of the jaundice. To achieve the&#x000a0;best outcomes, patients diagnosed with biliary atresia require&#x000a0;a Kasai operation (hepatic portoenterostomy) within the first 2 months of life to prevent irreversible liver damage.<xref ref-type="bibr" rid="article-23803.r41">[41]</xref>&#x000a0;The surgery involves the removal of the atretic biliary ducts and fibrous plate and anastomosis of the jejunum with the remaining ducts by a Roux-en-Y procedure to provide an alternative pathway for biliary drainage.<xref ref-type="bibr" rid="article-23803.r111">[111]</xref>&#x000a0;Infectious causes of cholestasis are&#x000a0;treated with specific antimicrobial agents, whereas treatment with cholic acid and chenodeoxycholic acid is often curative for many BASDs. Patients with GALD appear to respond well to IVIG and double-volume exchange transfusion. Patients with conditions&#x000a0;of cholestasis (eg, GALD and biliary atresia) and severe hepatic damage may require liver transplantation, which is curative but technically challenging in infants.<xref ref-type="bibr" rid="article-23803.r60">[60]</xref>&#x000a0;Parenteral nutrition-induced cholestasis is managed with cyclic PN, reducing the duration of exposure and initiating enteral feeds as early as possible. The manganese and copper content of PN should be monitored closely to minimize liver injury.</p>
      </sec>
      <sec id="article-23803.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnoses of jaundice are extensive.&#x000a0;(Refer to the<bold> Etiologies</bold>&#x000a0;section for more information on the causes of jaundice). The&#x000a0;onset of neonatal jaundice should prompt a timely evaluation to determine if the underlying etiology is a self-limited physiologic condition or a disease requiring treatment. Any neonate with yellowish skin and sclerae should be clinically diagnosed with jaundice. High carotene levels may cause yellowish skin&#x000a0;that mimics jaundice in older infants and children who are ingesting diets of breast milk or foods high in beta-carotene.<xref ref-type="bibr" rid="article-23803.r112">[112]</xref><xref ref-type="bibr" rid="article-23803.r38">[38]</xref>&#x000a0;However, with carotenemia, the sclera or mucosa are not involved, and neonates are not born with this benign condition. Visual assessment of the degree of jaundice is an unreliable screening tool for clinically significant hyperbilirubinemia. All newborns&#x000a0;should undergo an appropriate evaluation for possible jaundice before hospital discharge.<xref ref-type="bibr" rid="article-23803.r113">[113]</xref><xref ref-type="bibr" rid="article-23803.r114">[114]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-23803.s11" sec-type="Staging">
        <title>Staging</title>
        <p>
<bold>Acute Bilirubin Encephalopathy</bold>
</p>
        <p>The manifestations of bilirubin encephalopathy in&#x000a0;neonates&#x000a0;with severe unconjugated hyperbilirubinemia&#x000a0;depend on when the symptoms appear.&#x000a0;The level at which unconjugated bilirubin becomes neurotoxic is unclear, and kernicterus has been reported in infants&#x000a0;without markedly elevated bilirubin levels on autopsy.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440981/#BMJ_0319_REF4"/>&#x000a0;There are 3 phases of acute bilirubin encephalopathy, including:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Phase 1</bold>: The symptoms of phase 1&#x000a0;appear during the first 1 to 2 days of illness and are&#x000a0;notable for&#x000a0;poor feeding, lethargy, hypotonia, irritability, or frank seizures.</p>
          </list-item>
          <list-item>
            <p><bold>Phase 2</bold>: If infants continue to deteriorate, they progress to phase 2, characterized by increased extensor muscle tone,&#x000a0;exhibiting opisthotonus and retrocollis. This typically occurs during the middle of the first week of illness.</p>
          </list-item>
          <list-item>
            <p><bold>Phase 3</bold>:&#x000a0;After the first week, muscle rigidity, stupor or coma, apnea, or seizures may occur.</p>
          </list-item>
        </list>
        <p>
<bold>Chronic Blirubin Encephalopathy</bold>
</p>
        <p>This permanent and disabling neurologic condition, also known as kernicterus, is present in 2 forms, depending on the timing of symptoms.</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>In the first year:</bold> These patients present with hypotonia, exaggerated deep tendon reflexes, obligatory tonic neck reflexes, and delayed motor milestones.</p>
          </list-item>
          <list-item>
            <p><bold>Beyond the first year:</bold>&#x000a0;Patients exhibit movement disorders, most commonly choreo-athetoid cerebral palsy, dental enamel hypoplasia, upward gaze abnormality, and sensorineural hearing loss.<xref ref-type="bibr" rid="article-23803.r75">[75]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23803.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>With treatment, the prognosis for most&#x000a0;cases of unconjugated hyperbilirubinemia is excellent. In&#x000a0;patients with delayed or inadequate treatment, bilirubin encephalopathy may ensue.&#x000a0;The burden of bilirubin encephalopathy is significantly higher in developing and resource-limited nations.<xref ref-type="bibr" rid="article-23803.r71">[71]</xref>&#x000a0;Reports suggest a resurgence of kernicterus in countries where this complication had virtually disappeared, primarily attributed to the early hospital discharge of newborns with inadequate follow-up.&#x000a0;Patients with Crigler-Najjar type I carry a poor prognosis and require liver transplantation for a definitive cure. In the absence of liver transplantation, bilirubin encephalopathy is common.</p>
        <p>The prognosis for conjugated hyperbilirubinemia depends on the etiology. The prognosis of patients with biliary atresia is significantly improved by early diagnosis and surgery within 60 days of life. Similarly, patients with bile acid synthesis disorder (BASD) have excellent&#x000a0;outcomes and respond well to medical treatment. Historically, the outlook for gestational alloimmune liver disease (GALD) was poor, with up to 80% mortality without liver transplantation. However, with the advent of IVIG use and double volume exchange transfusion, the prognosis has&#x000a0;significantly improved in recent years.<xref ref-type="bibr" rid="article-23803.r115">[115]</xref>&#x000a0;The&#x000a0;outlook for most other&#x000a0;causes of cholestasis is often unfavorable, and many patients will require multidisciplinary interventions.</p>
      </sec>
      <sec id="article-23803.s13" sec-type="Complications">
        <title>Complications</title>
        <p>Newborns with severe hyperbilirubinemia are at risk for bilirubin-induced neurologic dysfunction (BIND). Bilirubin&#x000a0;binds to the globus pallidus, hippocampus, cerebellum, and subthalamic nuclear bodies, causing neurotoxicity.<xref ref-type="bibr" rid="article-23803.r116">[116]</xref>&#x000a0;Acute bilirubin encephalopathy (ABE) is characterized by lethargy, hypotonia, and decreased sucking. At this stage, the&#x000a0;condition is reversible. However, if ABE progresses, patients can develop irreversible chronic bilirubin encephalopathy or kernicterus. ABE manifests as choreo-athetoid cerebral palsy, seizures, arching, posturing, gaze abnormalities, dental enamel defects, and sensorineural hearing loss.&#x000a0;Infants&#x000a0;with neonatal cholestasis are also at risk of developing liver failure, cirrhosis, and even hepatocellular carcinoma in rare cases. Long-standing cholestasis may also lead to failure to thrive and fat-soluble vitamin deficiencies.</p>
      </sec>
      <sec id="article-23803.s14" sec-type="Consultations">
        <title>Consultations</title>
        <p>A pediatric or neonatal clinician&#x000a0;can manage most patients with unconjugated hyperbilirubinemia. However, patients suspected of having genetic causes of hyperbilirubinemia may need consultation and follow-up with a pediatric gastroenterologist, hematologist, and medical geneticist.</p>
        <p>However, patients with neonatal cholestasis should be referred to a pediatric gastroenterologist without delay. Most will need a comprehensive&#x000a0;investigation, and once&#x000a0;the etiology of cholestasis is identified, more&#x000a0;consultations may be warranted. Infants diagnosed with biliary atresia also need a referral to an experienced pediatric gastrointestinal surgeon for corrective surgery. Likewise, patients with inborn errors of metabolism&#x000a0;require a consultation with a metabolic specialist, a medical geneticist, and a pediatric dietician experienced in treating metabolic disorders. When BIND occurs, neurologic consultation and close follow-up are essential.&#x000a0;</p>
      </sec>
      <sec id="article-23803.s15" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>In 2022, the AAP published updated clinical guidelines for managing hyperbilirubinemia in the newborn. Prevention of hyperbilirubinemia begins in pregnancy. Pregnant women should be screened with Rh typing and treated appropriately. If the maternal antibody screen is positive or unknown, neonates should&#x000a0;undergo blood tests to determine blood type and DAT status. All newborns should&#x000a0;be assessed for risk factors increasing the risk of hyperbilirubinemia and frequently monitored&#x000a0;to prevent the occurrence of significant&#x000a0;jaundice.<xref ref-type="bibr" rid="article-23803.r34">[34]</xref>&#x000a0;</p>
        <p>Risk factors for significant hyperbilirubinemia include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Gestational age &#x0003c;38 weeks</p>
          </list-item>
          <list-item>
            <p>Jaundice at &#x0003c;24 hours of life</p>
          </list-item>
          <list-item>
            <p>Predischarge TSB or TcB close to the phototherapy threshold</p>
          </list-item>
          <list-item>
            <p>Evidence of hemolysis or rapidly rising TSB or TcB</p>
          </list-item>
          <list-item>
            <p>Phototherapy before hospital discharge</p>
          </list-item>
          <list-item>
            <p>Family history of a sibling or parent who required phototherapy or exchange transfusion</p>
          </list-item>
          <list-item>
            <p>Family history of RBC disorders, including G6PD deficiency</p>
          </list-item>
          <list-item>
            <p>Exclusive breastfeeding with suboptimal intake</p>
          </list-item>
          <list-item>
            <p>Scalp hematoma or significant bruising</p>
          </list-item>
          <list-item>
            <p>Down syndrome</p>
          </list-item>
          <list-item>
            <p>Large for gestational age infant of a mother with diabetes&#x000a0;<xref ref-type="bibr" rid="article-23803.r34">[34]</xref></p>
          </list-item>
        </list>
        <p>Risk factors for hyperbilirubinemia neurotoxicity that lower the threshold for phototherapy and escalation of care include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Gestational age &#x0003c;38 weeks</p>
          </list-item>
          <list-item>
            <p>Albumen &#x0003c;3.0 g/dL</p>
          </list-item>
          <list-item>
            <p>Hemolytic conditions</p>
          </list-item>
          <list-item>
            <p>Sepsis</p>
          </list-item>
          <list-item>
            <p>Significant clinical instability from any cause&#x000a0;<xref ref-type="bibr" rid="article-23803.r34">[34]</xref></p>
          </list-item>
        </list>
        <p>Because suboptimal feeding plays a role in&#x000a0;developing hyperbilirubinemia, all breastfeeding mothers should receive support to promote adequate feeding. Breastfeeding within the first hour of life is recommended, followed by on-demand nursing at least 8 times daily. Furthermore, staff should visually assess all hospitalized neonates for jaundice at least every 12 hours.&#x000a0;The AAP guidelines recommend universal bilirubin screening before discharge with TSB or TcB.<xref ref-type="bibr" rid="article-23803.r34">[34]</xref>&#x000a0;Most patients with unconjugated hyperbilirubinemia have an excellent prognosis, and&#x000a0;families should be reassured and&#x000a0;educated about the evaluation and indicated treatment when necessary.&#x000a0;Neonates with jaundice from etiologies with&#x000a0;poor prognoses often require multidisciplinary consultations, and parents should be adequately counseled and supported.&#x000a0;</p>
      </sec>
      <sec id="article-23803.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Neonatal jaundice is a common condition with&#x000a0;multiple etiologies. Most cases are&#x000a0;self-limiting with an excellent prognosis. However, bilirubin encephalopathy is an uncommon but&#x000a0;devastating complication of severe hyperbilirubinemia. Healthcare professionals&#x000a0;caring for newborns&#x000a0;must be aware of this. Nurses and parents are&#x000a0;usually&#x000a0;the first to notice and report jaundice or difficulties breastfeeding. While many conditions&#x000a0;causing jaundice are not diagnosed immediately, timely education about&#x000a0;risk factors for significant hyperbilirubinemia and neurotoxicity&#x000a0;is critical. Necessary treatment can begin while a diagnostic evaluation is in progress. Before discharge from the hospital, parents should be educated by nurses, nurse practitioners, pediatricians, obstetricians, and family practice&#x000a0;clinicians to monitor for jaundice at home and&#x000a0;know&#x000a0;when to seek follow-up medical care.&#x000a0;</p>
        <p>A simple two-color icterometer is a simple tool that helps&#x000a0;caregivers identify jaundice at home and may result in earlier medical intervention when indicated.<xref ref-type="bibr" rid="article-23803.r117">[117]</xref>&#x000a0;Nurses can train mothers to examine the skin and eyes of&#x000a0;their babies for jaundice,&#x000a0;either visually or with&#x000a0;a smartphone application. An interprofessional team&#x000a0;of clinicians, nurses, laboratory technicians,&#x000a0;subspecialists, and nutritionists&#x000a0;optimizes outcomes and must understand their role in caring for&#x000a0;jaundiced newborns, including current evidence-based guidelines. Nurses&#x000a0;are vital in monitoring treatments, educating parents, and keeping the team apprised&#x000a0;of&#x000a0;significant&#x000a0;changes in the patient's condition. Nurses ensure that the American Academy of Pediatrics recommendation for universal bilirubin screening and risk factor assessment is&#x000a0;performed to prevent the development of severe hyperbilirubinemia and improve patient outcomes.<xref ref-type="bibr" rid="article-23803.r8">[8]</xref></p>
      </sec>
      <sec id="article-23803.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23803&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23803">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/child-health/neonatal-jaundice/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=23803">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/23803/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=23803">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-23803.s18">
        <fig id="article-23803.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Metabolic Pathway for Bilirubin in the Hepatocyte. Bilirubin-G corresponds to bilirubin glucuronate; the donor is uridine diphosphate glucuronic acid (UDP-GA). This is catalyzed by the enzyme uridine diphosphate-glucuronyltransferase (UGT1A1). Gilbert and Crigler-Najjar syndrome is associated with decreases in UGT1A1 activity. Glutathione-S-transferase (GST) is a carrier protein that assists bilirubin uptake into the cytosol and may be implicated in Rotor syndrome. Contributed by R Kabir, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Kabir_Rotor__Syndrome" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-23803.s19">
        <title>References</title>
        <ref id="article-23803.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gale</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Seidman</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>Hyperbilirubinemia and early discharge.</article-title>
            <source>J Perinatol</source>
            <year>2001</year>
            <season>Jan-Feb</season>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>40</fpage>
            <page-range>40-3</page-range>
            <pub-id pub-id-type="pmid">11268867</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mitra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rennie</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Neonatal jaundice: aetiology, diagnosis and treatment.</article-title>
            <source>Br J Hosp Med (Lond)</source>
            <year>2017</year>
            <month>Dec</month>
            <day>02</day>
            <volume>78</volume>
            <issue>12</issue>
            <fpage>699</fpage>
            <page-range>699-704</page-range>
            <pub-id pub-id-type="pmid">29240507</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaplan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Renbaum</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Levy-Lahad</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hammerman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lahad</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Beutler</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>1997</year>
            <month>Oct</month>
            <day>28</day>
            <volume>94</volume>
            <issue>22</issue>
            <fpage>12128</fpage>
            <page-range>12128-32</page-range>
            <pub-id pub-id-type="pmid">9342374</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moncrieff</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Dunn</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Phototherapy for hyperbilirubinaemia in very low birthweight infants.</article-title>
            <source>Arch Dis Child</source>
            <year>1976</year>
            <month>Feb</month>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>124</fpage>
            <page-range>124-6</page-range>
            <pub-id pub-id-type="pmid">944021</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhutani</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Bilirubin-induced neurologic dysfunction (BIND).</article-title>
            <source>Semin Fetal Neonatal Med</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <pub-id pub-id-type="pmid">25577656</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ip</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kulig</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sege</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Glicken</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Maisels</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>J</given-names>
              </name>
              <collab>American Academy of Pediatrics Subcommittee on Hyperbilirubinemia</collab>
            </person-group>
            <article-title>An evidence-based review of important issues concerning neonatal hyperbilirubinemia.</article-title>
            <source>Pediatrics</source>
            <year>2004</year>
            <month>Jul</month>
            <volume>114</volume>
            <issue>1</issue>
            <fpage>e130</fpage>
            <page-range>e130-53</page-range>
            <pub-id pub-id-type="pmid">15231986</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leung</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Sauve</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Breastfeeding and breast milk jaundice.</article-title>
            <source>J R Soc Health</source>
            <year>1989</year>
            <month>Dec</month>
            <volume>109</volume>
            <issue>6</issue>
            <fpage>213</fpage>
            <page-range>213-7</page-range>
            <pub-id pub-id-type="pmid">2513410</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <collab>American Academy of Pediatrics Subcommittee on Hyperbilirubinemia</collab>
            <article-title>Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.</article-title>
            <source>Pediatrics</source>
            <year>2004</year>
            <month>Jul</month>
            <volume>114</volume>
            <issue>1</issue>
            <fpage>297</fpage>
            <page-range>297-316</page-range>
            <pub-id pub-id-type="pmid">15231951</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shahid</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Graba</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Outcome and cost analysis of implementing selective Coombs testing in the newborn nursery.</article-title>
            <source>J Perinatol</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>32</volume>
            <issue>12</issue>
            <fpage>966</fpage>
            <page-range>966-9</page-range>
            <pub-id pub-id-type="pmid">22441112</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Desjardins</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Blajchman</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Chintu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gent</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zipursky</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The spectrum of ABO hemolytic disease of the newborn infant.</article-title>
            <source>J Pediatr</source>
            <year>1979</year>
            <month>Sep</month>
            <volume>95</volume>
            <issue>3</issue>
            <fpage>447</fpage>
            <page-range>447-9</page-range>
            <pub-id pub-id-type="pmid">469673</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <article-title>ACOG practice bulletin. Prevention of Rh D alloimmunization. Number 4, May 1999 (replaces educational bulletin Number 147, October 1990). Clinical management guidelines for obstetrician-gynecologists. American College of Obstetrics and Gynecology.</article-title>
            <source>Int J Gynaecol Obstet</source>
            <year>1999</year>
            <month>Jul</month>
            <volume>66</volume>
            <issue>1</issue>
            <fpage>63</fpage>
            <page-range>63-70</page-range>
            <pub-id pub-id-type="pmid">10458556</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>G&#x000f3;mez-Manzo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Marcial-Quino</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vanoye-Carlo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Serrano-Posada</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ortega-Cuellar</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Valdez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Castillo-Rodr&#x000ed;guez</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Hern&#x000e1;ndez-Ochoa</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sierra-Palacios</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Bustamante</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Arreguin-Espinosa</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Glucose-6-Phosphate Dehydrogenase: Update and Analysis of New Mutations around the World.</article-title>
            <source>Int J Mol Sci</source>
            <year>2016</year>
            <month>Dec</month>
            <day>09</day>
            <volume>17</volume>
            <issue>12</issue>
            <pub-id pub-id-type="pmid">27941691</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grace</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Zanella</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Neufeld</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Morton</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Eber</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yaish</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Glader</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Erythrocyte pyruvate kinase deficiency: 2015 status report.</article-title>
            <source>Am J Hematol</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>90</volume>
            <issue>9</issue>
            <fpage>825</fpage>
            <page-range>825-30</page-range>
            <pub-id pub-id-type="pmid">26087744</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Da Costa</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Galimand</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fenneteau</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Mohandas</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Hereditary spherocytosis, elliptocytosis, and other red cell membrane disorders.</article-title>
            <source>Blood Rev</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>167</fpage>
            <page-range>167-78</page-range>
            <pub-id pub-id-type="pmid">23664421</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perrotta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gallagher</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Mohandas</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Hereditary spherocytosis.</article-title>
            <source>Lancet</source>
            <year>2008</year>
            <month>Oct</month>
            <day>18</day>
            <volume>372</volume>
            <issue>9647</issue>
            <fpage>1411</fpage>
            <page-range>1411-26</page-range>
            <pub-id pub-id-type="pmid">18940465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gallagher</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Weed</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Tse</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Benoit</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Morrow</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Marchesi</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Mohandas</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Forget</surname>
                <given-names>BG</given-names>
              </name>
            </person-group>
            <article-title>Recurrent fatal hydrops fetalis associated with a nucleotide substitution in the erythrocyte beta-spectrin gene.</article-title>
            <source>J Clin Invest</source>
            <year>1995</year>
            <month>Mar</month>
            <volume>95</volume>
            <issue>3</issue>
            <fpage>1174</fpage>
            <page-range>1174-82</page-range>
            <pub-id pub-id-type="pmid">7883966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McDonald</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Middleton</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dowswell</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>PS</given-names>
              </name>
            </person-group>
            <article-title>Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2013</year>
            <month>Jul</month>
            <day>11</day>
            <volume>2013</volume>
            <issue>7</issue>
            <fpage>CD004074</fpage>
            <pub-id pub-id-type="pmid">23843134</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fogarty</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Osborn</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Askie</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Seidler</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Hunter</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lui</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Simes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tarnow-Mordi</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Delayed vs early umbilical cord clamping for preterm infants: a systematic review and meta-analysis.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>218</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-18</page-range>
            <pub-id pub-id-type="pmid">29097178</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fenton</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>McNinch</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Bieda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dowling</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Damato</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Clinical Outcomes in Preterm Infants Following Institution of a Delayed Umbilical Cord Clamping Practice Change.</article-title>
            <source>Adv Neonatal Care</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>223</fpage>
            <page-range>223-231</page-range>
            <pub-id pub-id-type="pmid">29794839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakagawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ishida</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nagaoki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ohta</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shimabukuro</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hirata</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yamanaka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kusakawa</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Correlation between umbilical cord hemoglobin and rate of jaundice requiring phototherapy in healthy newborns.</article-title>
            <source>Pediatr Int</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>57</volume>
            <issue>4</issue>
            <fpage>626</fpage>
            <page-range>626-8</page-range>
            <pub-id pub-id-type="pmid">25533043</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bosma</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Chowdhury</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Bakker</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gantla</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>de Boer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Oostra</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Lindhout</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tytgat</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Jansen</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Oude Elferink</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.</article-title>
            <source>N Engl J Med</source>
            <year>1995</year>
            <month>Nov</month>
            <day>02</day>
            <volume>333</volume>
            <issue>18</issue>
            <fpage>1171</fpage>
            <page-range>1171-5</page-range>
            <pub-id pub-id-type="pmid">7565971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anderson</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>Calkins</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Neonatal Indirect Hyperbilirubinemia.</article-title>
            <source>Neoreviews</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>21</volume>
            <issue>11</issue>
            <fpage>e749</fpage>
            <page-range>e749-e760</page-range>
            <pub-id pub-id-type="pmid">33139512</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maruo</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nakahara</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yanagi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nomura</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mimura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Matsui</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Takeuchi</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type II and Gilbert syndrome.</article-title>
            <source>J Gastroenterol Hepatol</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>403</fpage>
            <page-range>403-8</page-range>
            <pub-id pub-id-type="pmid">26250421</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flaherman</surname>
                <given-names>VJ</given-names>
              </name>
              <name>
                <surname>Maisels</surname>
                <given-names>MJ</given-names>
              </name>
              <collab>Academy of Breastfeeding Medicine</collab>
            </person-group>
            <article-title>ABM Clinical Protocol #22: Guidelines for Management of Jaundice in the Breastfeeding Infant 35 Weeks or More of Gestation-Revised 2017.</article-title>
            <source>Breastfeed Med</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>12</volume>
            <issue>5</issue>
            <fpage>250</fpage>
            <page-range>250-257</page-range>
            <pub-id pub-id-type="pmid">29624434</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grunebaum</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Amir</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Merlob</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mimouni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Varsano</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Breast mild jaundice: natural history, familial incidence and late neurodevelopmental outcome of the infant.</article-title>
            <source>Eur J Pediatr</source>
            <year>1991</year>
            <month>Feb</month>
            <volume>150</volume>
            <issue>4</issue>
            <fpage>267</fpage>
            <page-range>267-70</page-range>
            <pub-id pub-id-type="pmid">2029918</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Preer</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Philipp</surname>
                <given-names>BL</given-names>
              </name>
            </person-group>
            <article-title>Understanding and managing breast milk jaundice.</article-title>
            <source>Arch Dis Child Fetal Neonatal Ed</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>96</volume>
            <issue>6</issue>
            <fpage>F461</fpage>
            <page-range>F461-6</page-range>
            <pub-id pub-id-type="pmid">20688866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rubarth</surname>
                <given-names>LB</given-names>
              </name>
            </person-group>
            <article-title>Infants of diabetic mothers.</article-title>
            <source>Neonatal Netw</source>
            <year>2013</year>
            <season>Nov-Dec</season>
            <volume>32</volume>
            <issue>6</issue>
            <fpage>416</fpage>
            <page-range>416-8</page-range>
            <pub-id pub-id-type="pmid">24195802</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amin</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <article-title>Clinical assessment of bilirubin-induced neurotoxicity in premature infants.</article-title>
            <source>Semin Perinatol</source>
            <year>2004</year>
            <month>Oct</month>
            <volume>28</volume>
            <issue>5</issue>
            <fpage>340</fpage>
            <page-range>340-7</page-range>
            <pub-id pub-id-type="pmid">15686265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maisels</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Kring</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Risk of sepsis in newborns with severe hyperbilirubinemia.</article-title>
            <source>Pediatrics</source>
            <year>1992</year>
            <month>Nov</month>
            <volume>90</volume>
            <issue>5</issue>
            <fpage>741</fpage>
            <page-range>741-3</page-range>
            <pub-id pub-id-type="pmid">1408547</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hansen</surname>
                <given-names>TW</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic approaches to neonatal jaundice: an international survey.</article-title>
            <source>Clin Pediatr (Phila)</source>
            <year>1996</year>
            <month>Jun</month>
            <volume>35</volume>
            <issue>6</issue>
            <fpage>309</fpage>
            <page-range>309-16</page-range>
            <pub-id pub-id-type="pmid">8782955</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maisels</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Watchko</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Bhutani</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation.</article-title>
            <source>J Perinatol</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>32</volume>
            <issue>9</issue>
            <fpage>660</fpage>
            <page-range>660-4</page-range>
            <pub-id pub-id-type="pmid">22678141</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McDonagh</surname>
                <given-names>AF</given-names>
              </name>
            </person-group>
            <article-title>Is bilirubin good for you?</article-title>
            <source>Clin Perinatol</source>
            <year>1990</year>
            <month>Jun</month>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>359</fpage>
            <page-range>359-69</page-range>
            <pub-id pub-id-type="pmid">2196134</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hegyi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Goldie</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hiatt</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The protective role of bilirubin in oxygen-radical diseases of the preterm infant.</article-title>
            <source>J Perinatol</source>
            <year>1994</year>
            <season>Jul-Aug</season>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>296</fpage>
            <page-range>296-300</page-range>
            <pub-id pub-id-type="pmid">7965225</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beal</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>American Academy of Pediatrics' Updated Clinical Guidelines for Managing Neonatal Hyperbilirubinemia.</article-title>
            <source>MCN Am J Matern Child Nurs</source>
            <string-date>2023 Jan-Feb 01</string-date>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>49</fpage>
            <pub-id pub-id-type="pmid">36469895</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fawaz</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Baumann</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Ekong</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Fischler</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hadzic</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>McLin</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Molleston</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Neimark</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Karpen</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Guideline for the Evaluation of Cholestatic Jaundice in Infants: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.</article-title>
            <source>J Pediatr Gastroenterol Nutr</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>64</volume>
            <issue>1</issue>
            <fpage>154</fpage>
            <page-range>154-168</page-range>
            <pub-id pub-id-type="pmid">27429428</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Plosa</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Esbenshade</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Fuller</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Weitkamp</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Cytomegalovirus infection.</article-title>
            <source>Pediatr Rev</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>156</fpage>
            <page-range>156-63; quiz 163</page-range>
            <pub-id pub-id-type="pmid">22474112</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roelofsen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>van der Veere</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Ottenhoff</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Schoemaker</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jansen</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Oude Elferink</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>Decreased bilirubin transport in the perfused liver of endotoxemic rats.</article-title>
            <source>Gastroenterology</source>
            <year>1994</year>
            <month>Oct</month>
            <volume>107</volume>
            <issue>4</issue>
            <fpage>1075</fpage>
            <page-range>1075-84</page-range>
            <pub-id pub-id-type="pmid">7926459</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pan</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Rivas</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Jaundice: Newborn to Age 2 Months.</article-title>
            <source>Pediatr Rev</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>38</volume>
            <issue>11</issue>
            <fpage>499</fpage>
            <page-range>499-510</page-range>
            <pub-id pub-id-type="pmid">29093118</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>The</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Honein</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Caton</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Siega-Riz</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Druschel</surname>
                <given-names>CM</given-names>
              </name>
              <collab>National Birth Defects Prevention Study</collab>
            </person-group>
            <article-title>Risk factors for isolated biliary atresia, National Birth Defects Prevention Study, 1997-2002.</article-title>
            <source>Am J Med Genet A</source>
            <year>2007</year>
            <month>Oct</month>
            <day>01</day>
            <volume>143A</volume>
            <issue>19</issue>
            <fpage>2274</fpage>
            <page-range>2274-84</page-range>
            <pub-id pub-id-type="pmid">17726689</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takamizawa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zaima</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Muraji</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kanegawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Akasaka</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Satoh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nishijima</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Can biliary atresia be diagnosed by ultrasonography alone?</article-title>
            <source>J Pediatr Surg</source>
            <year>2007</year>
            <month>Dec</month>
            <volume>42</volume>
            <issue>12</issue>
            <fpage>2093</fpage>
            <page-range>2093-6</page-range>
            <pub-id pub-id-type="pmid">18082715</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Serinet</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Wildhaber</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Brou&#x000e9;</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lachaux</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sarles</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jacquemin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gauthier</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chardot</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Impact of age at Kasai operation on its results in late childhood and adolescence: a rational basis for biliary atresia screening.</article-title>
            <source>Pediatrics</source>
            <year>2009</year>
            <month>May</month>
            <volume>123</volume>
            <issue>5</issue>
            <fpage>1280</fpage>
            <page-range>1280-6</page-range>
            <pub-id pub-id-type="pmid">19403492</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Balistreri</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Bezerra</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Whatever happened to "neonatal hepatitis"?</article-title>
            <source>Clin Liver Dis</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>27</fpage>
            <page-range>27-53, v</page-range>
            <pub-id pub-id-type="pmid">16376793</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soares</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Arnaoutakis</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Kamel</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Rastegar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Anders</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Maithel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pawlik</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Choledochal cysts: presentation, clinical differentiation, and management.</article-title>
            <source>J Am Coll Surg</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>219</volume>
            <issue>6</issue>
            <fpage>1167</fpage>
            <page-range>1167-80</page-range>
            <pub-id pub-id-type="pmid">25442379</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amedee-Manesme</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Bernard</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Brunelle</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hadchouel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Polonovski</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Baudon</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Beguet</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Alagille</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Sclerosing cholangitis with neonatal onset.</article-title>
            <source>J Pediatr</source>
            <year>1987</year>
            <month>Aug</month>
            <volume>111</volume>
            <issue>2</issue>
            <fpage>225</fpage>
            <page-range>225-9</page-range>
            <pub-id pub-id-type="pmid">3612394</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ljung</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ivarsson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nilsson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Solvig</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wattsg&#x000e5;rd</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Borulf</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Cholelithiasis during the first year of life: case reports and literature review.</article-title>
            <source>Acta Paediatr</source>
            <year>1992</year>
            <month>Jan</month>
            <volume>81</volume>
            <issue>1</issue>
            <fpage>69</fpage>
            <page-range>69-72</page-range>
            <pub-id pub-id-type="pmid">1600308</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jesina</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Alagille Syndrome: An Overview.</article-title>
            <source>Neonatal Netw</source>
            <year>2017</year>
            <month>Nov</month>
            <day>01</day>
            <volume>36</volume>
            <issue>6</issue>
            <fpage>343</fpage>
            <page-range>343-347</page-range>
            <pub-id pub-id-type="pmid">29185945</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Emerick</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Rand</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Goldmuntz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Krantz</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Spinner</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>Piccoli</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Features of Alagille syndrome in 92 patients: frequency and relation to prognosis.</article-title>
            <source>Hepatology</source>
            <year>1999</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>822</fpage>
            <page-range>822-9</page-range>
            <pub-id pub-id-type="pmid">10051485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Gong</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>[Infantile cholestasis caused by CFTR mutation: case report and literature review].</article-title>
            <source>Zhonghua Er Ke Za Zhi</source>
            <year>2016</year>
            <month>Nov</month>
            <day>02</day>
            <volume>54</volume>
            <issue>11</issue>
            <fpage>851</fpage>
            <page-range>851-855</page-range>
            <pub-id pub-id-type="pmid">27806795</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Townsend</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Newsome</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Turner</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Presentation and prognosis of liver disease in alpha-1 antitrypsin deficiency.</article-title>
            <source>Expert Rev Gastroenterol Hepatol</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>12</volume>
            <issue>8</issue>
            <fpage>745</fpage>
            <page-range>745-747</page-range>
            <pub-id pub-id-type="pmid">29768056</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karadag</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zenciroglu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Eminoglu</surname>
                <given-names>FT</given-names>
              </name>
              <name>
                <surname>Dilli</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Karagol</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Kundak</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dursun</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hakan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Okumus</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Literature review and outcome of classic galactosemia diagnosed in the neonatal period.</article-title>
            <source>Clin Lab</source>
            <year>2013</year>
            <volume>59</volume>
            <issue>9-10</issue>
            <fpage>1139</fpage>
            <page-range>1139-46</page-range>
            <pub-id pub-id-type="pmid">24273939</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chinsky</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ficicioglu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>van Karnebeek</surname>
                <given-names>CDM</given-names>
              </name>
              <name>
                <surname>Grompe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Waisbren</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Gucsavas-Calikoglu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wasserstein</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Coakley</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations.</article-title>
            <source>Genet Med</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>19</volume>
            <issue>12</issue>
            <pub-id pub-id-type="pmid">28771246</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jacquemin</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Progressive familial intrahepatic cholestasis. Genetic basis and treatment.</article-title>
            <source>Clin Liver Dis</source>
            <year>2000</year>
            <month>Nov</month>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>753</fpage>
            <page-range>753-63</page-range>
            <pub-id pub-id-type="pmid">11232355</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davit-Spraul</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gonzales</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Baussan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jacquemin</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Progressive familial intrahepatic cholestasis.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2009</year>
            <month>Jan</month>
            <day>08</day>
            <volume>4</volume>
            <fpage>1</fpage>
            <pub-id pub-id-type="pmid">19133130</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bull</surname>
                <given-names>LN</given-names>
              </name>
              <name>
                <surname>Roche</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Pedersen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Knisely</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>van Der Hagen</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Eiklid</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Aagenaes</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Freimer</surname>
                <given-names>NB</given-names>
              </name>
            </person-group>
            <article-title>Mapping of the locus for cholestasis-lymphedema syndrome (Aagenaes syndrome) to a 6.6-cM interval on chromosome 15q.</article-title>
            <source>Am J Hum Genet</source>
            <year>2000</year>
            <month>Oct</month>
            <volume>67</volume>
            <issue>4</issue>
            <fpage>994</fpage>
            <page-range>994-9</page-range>
            <pub-id pub-id-type="pmid">10968776</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strassburg</surname>
                <given-names>CP</given-names>
              </name>
            </person-group>
            <article-title>Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome).</article-title>
            <source>Best Pract Res Clin Gastroenterol</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>24</volume>
            <issue>5</issue>
            <fpage>555</fpage>
            <page-range>555-71</page-range>
            <pub-id pub-id-type="pmid">20955959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lauriti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Aufieri</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cananzi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chiesa</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Eaton</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pierro</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Incidence, prevention, and treatment of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in infants and children: a systematic review.</article-title>
            <source>JPEN J Parenter Enteral Nutr</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>38</volume>
            <issue>1</issue>
            <fpage>70</fpage>
            <page-range>70-85</page-range>
            <pub-id pub-id-type="pmid">23894170</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buchman</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Iyer</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fryer</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation.</article-title>
            <source>Hepatology</source>
            <year>2006</year>
            <month>Jan</month>
            <volume>43</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-19</page-range>
            <pub-id pub-id-type="pmid">16374841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duerksen</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Van Aerde</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Thomson</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Jewell</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Clandinin</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Total parenteral nutrition impairs bile flow and alters bile composition in newborn piglet.</article-title>
            <source>Dig Dis Sci</source>
            <year>1996</year>
            <month>Sep</month>
            <volume>41</volume>
            <issue>9</issue>
            <fpage>1864</fpage>
            <page-range>1864-70</page-range>
            <pub-id pub-id-type="pmid">8794808</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pan</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Melin-Aldana</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Malladi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Whitington</surname>
                <given-names>PF</given-names>
              </name>
            </person-group>
            <article-title>Novel mechanism of fetal hepatocyte injury in congenital alloimmune hepatitis involves the terminal complement cascade.</article-title>
            <source>Hepatology</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>51</volume>
            <issue>6</issue>
            <fpage>2061</fpage>
            <page-range>2061-8</page-range>
            <pub-id pub-id-type="pmid">20512994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feldman</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Whitington</surname>
                <given-names>PF</given-names>
              </name>
            </person-group>
            <article-title>Neonatal hemochromatosis.</article-title>
            <source>J Clin Exp Hepatol</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>3</volume>
            <issue>4</issue>
            <fpage>313</fpage>
            <page-range>313-20</page-range>
            <pub-id pub-id-type="pmid">25755519</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhutani</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Stark</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Lazzeroni</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Poland</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gourley</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Kazmierczak</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Meloy</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Burgos</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>DK</given-names>
              </name>
              <collab>Initial Clinical Testing Evaluation and Risk Assessment for Universal Screening for Hyperbilirubinemia Study Group</collab>
            </person-group>
            <article-title>Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy.</article-title>
            <source>J Pediatr</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>162</volume>
            <issue>3</issue>
            <fpage>477</fpage>
            <page-range>477-482.e1</page-range>
            <pub-id pub-id-type="pmid">23043681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhutani</surname>
                <given-names>VK</given-names>
              </name>
            </person-group>
            <article-title>Editorial: building evidence to manage newborn jaundice worldwide.</article-title>
            <source>Indian J Pediatr</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>79</volume>
            <issue>2</issue>
            <fpage>253</fpage>
            <page-range>253-5</page-range>
            <pub-id pub-id-type="pmid">22183759</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alkhotani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Eldin</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Zaghloul</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mujahid</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of neonatal jaundice in the Makkah region.</article-title>
            <source>Sci Rep</source>
            <year>2014</year>
            <month>Apr</month>
            <day>25</day>
            <volume>4</volume>
            <fpage>4802</fpage>
            <pub-id pub-id-type="pmid">24763104</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Winfield</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>MacFaul</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Clinical study of prolonged jaundice in breast- and bottle-fed babies.</article-title>
            <source>Arch Dis Child</source>
            <year>1978</year>
            <month>Jun</month>
            <volume>53</volume>
            <issue>6</issue>
            <fpage>506</fpage>
            <page-range>506-7</page-range>
            <pub-id pub-id-type="pmid">686778</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sgro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Incidence and causes of severe neonatal hyperbilirubinemia in Canada.</article-title>
            <source>CMAJ</source>
            <year>2006</year>
            <month>Sep</month>
            <day>12</day>
            <volume>175</volume>
            <issue>6</issue>
            <fpage>587</fpage>
            <page-range>587-90</page-range>
            <pub-id pub-id-type="pmid">16966660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ding</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Na</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>An epidemiological survey on neonatal jaundice in China.</article-title>
            <source>Chin Med J (Engl)</source>
            <year>2001</year>
            <month>Apr</month>
            <volume>114</volume>
            <issue>4</issue>
            <fpage>344</fpage>
            <page-range>344-7</page-range>
            <pub-id pub-id-type="pmid">11780450</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhutani</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Zipursky</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Blencowe</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Khanna</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sgro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ebbesen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mori</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Slusher</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Fahmy</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Paul</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Okolo</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>de Almeida</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Olusanya</surname>
                <given-names>BO</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cousens</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lawn</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels.</article-title>
            <source>Pediatr Res</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>74 Suppl 1</volume>
            <issue>Suppl 1</issue>
            <fpage>86</fpage>
            <page-range>86-100</page-range>
            <pub-id pub-id-type="pmid">24366465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moore</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Newberry</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Freeby</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Crnic</surname>
                <given-names>LS</given-names>
              </name>
            </person-group>
            <article-title>Increased incidence of neonatal hyperbilirubinemia at 3,100 m in Colorado.</article-title>
            <source>Am J Dis Child</source>
            <year>1984</year>
            <month>Feb</month>
            <volume>138</volume>
            <issue>2</issue>
            <fpage>157</fpage>
            <page-range>157-61</page-range>
            <pub-id pub-id-type="pmid">6695871</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drew</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Barrie</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Horacek</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kitchen</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>Factors influencing jaundice in immigrant Greek infants.</article-title>
            <source>Arch Dis Child</source>
            <year>1978</year>
            <month>Jan</month>
            <volume>53</volume>
            <issue>1</issue>
            <fpage>49</fpage>
            <page-range>49-52</page-range>
            <pub-id pub-id-type="pmid">626518</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <article-title>Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation) - Summary.</article-title>
            <source>Paediatr Child Health</source>
            <year>2007</year>
            <month>May</month>
            <volume>12</volume>
            <issue>5</issue>
            <fpage>401</fpage>
            <page-range>401-18</page-range>
            <pub-id pub-id-type="pmid">19030400</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Watchko</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Tiribelli</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Bilirubin-induced neurologic damage--mechanisms and management approaches.</article-title>
            <source>N Engl J Med</source>
            <year>2013</year>
            <month>Nov</month>
            <day>21</day>
            <volume>369</volume>
            <issue>21</issue>
            <fpage>2021</fpage>
            <page-range>2021-30</page-range>
            <pub-id pub-id-type="pmid">24256380</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dick</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Mowat</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Hepatitis syndrome in infancy--an epidemiological survey with 10 year follow up.</article-title>
            <source>Arch Dis Child</source>
            <year>1985</year>
            <month>Jun</month>
            <volume>60</volume>
            <issue>6</issue>
            <fpage>512</fpage>
            <page-range>512-6</page-range>
            <pub-id pub-id-type="pmid">3874604</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gottesman</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Del Vecchio</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Aronoff</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Etiologies of conjugated hyperbilirubinemia in infancy: a systematic review of 1692 subjects.</article-title>
            <source>BMC Pediatr</source>
            <year>2015</year>
            <month>Nov</month>
            <day>20</day>
            <volume>15</volume>
            <fpage>192</fpage>
            <pub-id pub-id-type="pmid">26589959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D'Alessandro</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Knechtle</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Chin</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Fernandez</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Yagci</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Leverson</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kalayoglu</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Liver transplantation in pediatric patients: twenty years of experience at the University of Wisconsin.</article-title>
            <source>Pediatr Transplant</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>11</volume>
            <issue>6</issue>
            <fpage>661</fpage>
            <page-range>661-70</page-range>
            <pub-id pub-id-type="pmid">17663691</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dennery</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Seidman</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>Neonatal hyperbilirubinemia.</article-title>
            <source>N Engl J Med</source>
            <year>2001</year>
            <month>Feb</month>
            <day>22</day>
            <volume>344</volume>
            <issue>8</issue>
            <fpage>581</fpage>
            <page-range>581-90</page-range>
            <pub-id pub-id-type="pmid">11207355</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poland</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Odell</surname>
                <given-names>GB</given-names>
              </name>
            </person-group>
            <article-title>Physiologic jaundice: the enterohepatic circulation of bilirubin.</article-title>
            <source>N Engl J Med</source>
            <year>1971</year>
            <month>Jan</month>
            <day>07</day>
            <volume>284</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-6</page-range>
            <pub-id pub-id-type="pmid">4922346</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brouillard</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>Measurement of red blood cell life-span.</article-title>
            <source>JAMA</source>
            <year>1974</year>
            <month>Dec</month>
            <day>02</day>
            <volume>230</volume>
            <issue>9</issue>
            <fpage>1304</fpage>
            <page-range>1304-5</page-range>
            <pub-id pub-id-type="pmid">4479604</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chuniaud</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dessante</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chantoux</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Blondeau</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Francon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Trivin</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Cytotoxicity of bilirubin for human fibroblasts and rat astrocytes in culture. Effect of the ratio of bilirubin to serum albumin.</article-title>
            <source>Clin Chim Acta</source>
            <year>1996</year>
            <month>Dec</month>
            <day>30</day>
            <volume>256</volume>
            <issue>2</issue>
            <fpage>103</fpage>
            <page-range>103-14</page-range>
            <pub-id pub-id-type="pmid">9027422</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amato</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Kilguss</surname>
                <given-names>NV</given-names>
              </name>
              <name>
                <surname>Gelardi</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Cashore</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Dose-effect relationship of bilirubin on striatal synaptosomes in rats.</article-title>
            <source>Biol Neonate</source>
            <year>1994</year>
            <volume>66</volume>
            <issue>5</issue>
            <fpage>288</fpage>
            <page-range>288-93</page-range>
            <pub-id pub-id-type="pmid">7873694</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoffman</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Zanelli</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Kubin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>OP</given-names>
              </name>
              <name>
                <surname>Delivoria-Papadopoulos</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The in vivo effect of bilirubin on the N-methyl-D-aspartate receptor/ion channel complex in the brains of newborn piglets.</article-title>
            <source>Pediatr Res</source>
            <year>1996</year>
            <month>Dec</month>
            <volume>40</volume>
            <issue>6</issue>
            <fpage>804</fpage>
            <page-range>804-8</page-range>
            <pub-id pub-id-type="pmid">8947954</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benchimol</surname>
                <given-names>EI</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Ling</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Early diagnosis of neonatal cholestatic jaundice: test at 2 weeks.</article-title>
            <source>Can Fam Physician</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>55</volume>
            <issue>12</issue>
            <fpage>1184</fpage>
            <page-range>1184-92</page-range>
            <pub-id pub-id-type="pmid">20008595</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trauner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Meier</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Boyer</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Molecular pathogenesis of cholestasis.</article-title>
            <source>N Engl J Med</source>
            <year>1998</year>
            <month>Oct</month>
            <day>22</day>
            <volume>339</volume>
            <issue>17</issue>
            <fpage>1217</fpage>
            <page-range>1217-27</page-range>
            <pub-id pub-id-type="pmid">9780343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Liou</surname>
                <given-names>BY</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases.</article-title>
            <source>J Biomed Sci</source>
            <year>2018</year>
            <month>Oct</month>
            <day>26</day>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>75</fpage>
            <pub-id pub-id-type="pmid">30367658</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hamza</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Kernicterus.</article-title>
            <source>Autops Case Rep</source>
            <year>2019</year>
            <season>Jan-Mar</season>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>e2018057</fpage>
            <pub-id pub-id-type="pmid">30863731</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vij</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rela</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Biliary atresia: pathology, etiology and pathogenesis.</article-title>
            <source>Future Sci OA</source>
            <year>2020</year>
            <month>Mar</month>
            <day>17</day>
            <volume>6</volume>
            <issue>5</issue>
            <fpage>FSO466</fpage>
            <pub-id pub-id-type="pmid">32518681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matthai</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Paul</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of cholestatic jaundice in young infants.</article-title>
            <source>Indian Pediatr</source>
            <year>2001</year>
            <month>Aug</month>
            <volume>38</volume>
            <issue>8</issue>
            <fpage>893</fpage>
            <page-range>893-8</page-range>
            <pub-id pub-id-type="pmid">11521001</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maisels</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Bhutani</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Bogen</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Stark</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Watchko</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Hyperbilirubinemia in the newborn infant &#x0003e; or =35 weeks' gestation: an update with clarifications.</article-title>
            <source>Pediatrics</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>124</volume>
            <issue>4</issue>
            <fpage>1193</fpage>
            <page-range>1193-8</page-range>
            <pub-id pub-id-type="pmid">19786452</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bhutani</surname>
                <given-names>VK</given-names>
              </name>
            </person-group>
            <article-title>Guidelines for management of the jaundiced term and near-term infant.</article-title>
            <source>Clin Perinatol</source>
            <year>1998</year>
            <month>Sep</month>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>555</fpage>
            <page-range>555-74, viii</page-range>
            <pub-id pub-id-type="pmid">9779334</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kemper</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Slaughter</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Maisels</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Watchko</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Downs</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Grout</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Bundy</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Stark</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Bogen</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Feldman-Winter</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Bhutani</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Maradiaga Panayotti</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Okechukwu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rappo</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>TL</given-names>
              </name>
            </person-group>
            <article-title>Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation.</article-title>
            <source>Pediatrics</source>
            <year>2022</year>
            <month>Sep</month>
            <day>01</day>
            <volume>150</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">35927462</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wainer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rabi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Parmar</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Allegro</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lyon</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Impact of skin tone on the performance of a transcutaneous jaundice meter.</article-title>
            <source>Acta Paediatr</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>98</volume>
            <issue>12</issue>
            <fpage>1909</fpage>
            <page-range>1909-15</page-range>
            <pub-id pub-id-type="pmid">19764923</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Casnocha Lucanova</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Matasova</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zibolen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Krcho</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Accuracy of transcutaneous bilirubin measurement in newborns after phototherapy.</article-title>
            <source>J Perinatol</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>36</volume>
            <issue>10</issue>
            <fpage>858</fpage>
            <page-range>858-61</page-range>
            <pub-id pub-id-type="pmid">27279078</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hulzebos</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>Dijk</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>van Imhoff</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Bos</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Lopriore</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Offringa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ruiter</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>van Braeckel</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Krabbe</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Quik</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>van Toledo-Eppinga</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nuytemans</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>van Wassenaer-Leemhuis</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Benders</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Korbeeck-van Hof</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>van Lingen</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Groot Jebbink</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Liem</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mansvelt</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Buijs</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Govaert</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>van Vliet</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mulder</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Wolfs</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fetter</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Laarman</surname>
                <given-names>C</given-names>
              </name>
              <collab>BARTrial Study Group</collab>
            </person-group>
            <article-title>The bilirubin albumin ratio in the management of hyperbilirubinemia in preterm infants to improve neurodevelopmental outcome: a randomized controlled trial--BARTrial.</article-title>
            <source>PLoS One</source>
            <year>2014</year>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>e99466</fpage>
            <pub-id pub-id-type="pmid">24927259</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steinborn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Seelos</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Heuck</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>von Voss</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Reiser</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>MR findings in a patient with Kernicterus.</article-title>
            <source>Eur Radiol</source>
            <year>1999</year>
            <volume>9</volume>
            <issue>9</issue>
            <fpage>1913</fpage>
            <page-range>1913-5</page-range>
            <pub-id pub-id-type="pmid">10602975</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McKiernan</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>The frequency and outcome of biliary atresia in the UK and Ireland.</article-title>
            <source>Lancet</source>
            <year>2000</year>
            <month>Jan</month>
            <day>01</day>
            <volume>355</volume>
            <issue>9197</issue>
            <fpage>25</fpage>
            <page-range>25-9</page-range>
            <pub-id pub-id-type="pmid">10615887</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morotti</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Pediatric Cholestatic Disorders: Approach to Pathologic Diagnosis.</article-title>
            <source>Surg Pathol Clin</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>205</fpage>
            <page-range>205-25</page-range>
            <pub-id pub-id-type="pmid">26838972</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhutani</surname>
                <given-names>VK</given-names>
              </name>
              <collab>Committee on Fetus and Newborn</collab>
              <collab>American Academy of Pediatrics</collab>
            </person-group>
            <article-title>Phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.</article-title>
            <source>Pediatrics</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>128</volume>
            <issue>4</issue>
            <fpage>e1046</fpage>
            <page-range>e1046-52</page-range>
            <pub-id pub-id-type="pmid">21949150</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yetman</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Parks</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Huseby</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Mistry</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Rebound bilirubin levels in infants receiving phototherapy.</article-title>
            <source>J Pediatr</source>
            <year>1998</year>
            <month>Nov</month>
            <volume>133</volume>
            <issue>5</issue>
            <fpage>705</fpage>
            <page-range>705-7</page-range>
            <pub-id pub-id-type="pmid">9821435</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Newman</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>YW</given-names>
              </name>
              <name>
                <surname>Kuzniewicz</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Grimes</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>McCulloch</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>Childhood Seizures After Phototherapy.</article-title>
            <source>Pediatrics</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>142</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">30249623</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Newman</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Wickremasinghe</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Grimes</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>McCulloch</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Kuzniewicz</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>Retrospective Cohort Study of Phototherapy and Childhood Cancer in Northern California.</article-title>
            <source>Pediatrics</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>137</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">27217477</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Auger</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Laverdi&#x000e8;re</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ayoub</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Luu</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Neonatal phototherapy and future risk of childhood cancer.</article-title>
            <source>Int J Cancer</source>
            <year>2019</year>
            <month>Oct</month>
            <day>15</day>
            <volume>145</volume>
            <issue>8</issue>
            <fpage>2061</fpage>
            <page-range>2061-2069</page-range>
            <pub-id pub-id-type="pmid">30684392</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r101">
          <label>101</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cai</surname>
                <given-names>WQ</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Challenges of phototherapy for neonatal hyperbilirubinemia (Review).</article-title>
            <source>Exp Ther Med</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>231</fpage>
            <pub-id pub-id-type="pmid">33613704</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r102">
          <label>102</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Itoh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Okada</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kuboi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kusaka</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Phototherapy for neonatal hyperbilirubinemia.</article-title>
            <source>Pediatr Int</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>59</volume>
            <issue>9</issue>
            <fpage>959</fpage>
            <page-range>959-966</page-range>
            <pub-id pub-id-type="pmid">28563973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r103">
          <label>103</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mohankar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Krishnan</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Bronze baby syndrome.</article-title>
            <source>Indian Pediatr</source>
            <year>2013</year>
            <month>Jun</month>
            <day>08</day>
            <volume>50</volume>
            <issue>6</issue>
            <fpage>624</fpage>
            <pub-id pub-id-type="pmid">23942414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r104">
          <label>104</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pearson</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Replacement transfusion as a treatment of erythroblastosis fetalis, by Louis K. Diamond, MD, Pediatrics, 1948;2:520-524.</article-title>
            <source>Pediatrics</source>
            <year>1998</year>
            <month>Jul</month>
            <volume>102</volume>
            <issue>1 Pt 2</issue>
            <fpage>203</fpage>
            <page-range>203-5</page-range>
            <pub-id pub-id-type="pmid">9651427</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r105">
          <label>105</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hansen</surname>
                <given-names>TWR</given-names>
              </name>
              <name>
                <surname>Maisels</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Ebbesen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vreman</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Bhutani</surname>
                <given-names>VK</given-names>
              </name>
            </person-group>
            <article-title>Sixty years of phototherapy for neonatal jaundice - from serendipitous observation to standardized treatment and rescue for millions.</article-title>
            <source>J Perinatol</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>40</volume>
            <issue>2</issue>
            <fpage>180</fpage>
            <page-range>180-193</page-range>
            <pub-id pub-id-type="pmid">31420582</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r106">
          <label>106</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DIAMOND</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>ALLEN</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>THOMAS</surname>
                <given-names>WO</given-names>
              </name>
            </person-group>
            <article-title>Erythroblastosis fetalis. VII. Treatment with exchange transfusion.</article-title>
            <source>N Engl J Med</source>
            <year>1951</year>
            <month>Jan</month>
            <day>11</day>
            <volume>244</volume>
            <issue>2</issue>
            <fpage>39</fpage>
            <page-range>39-49</page-range>
            <pub-id pub-id-type="pmid">14785788</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r107">
          <label>107</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jackson</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Adverse events associated with exchange transfusion in healthy and ill newborns.</article-title>
            <source>Pediatrics</source>
            <year>1997</year>
            <month>May</month>
            <volume>99</volume>
            <issue>5</issue>
            <fpage>E7</fpage>
            <pub-id pub-id-type="pmid">9113964</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r108">
          <label>108</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patra</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Storfer-Isser</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Siner</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hack</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Adverse events associated with neonatal exchange transfusion in the 1990s.</article-title>
            <source>J Pediatr</source>
            <year>2004</year>
            <month>May</month>
            <volume>144</volume>
            <issue>5</issue>
            <fpage>626</fpage>
            <page-range>626-31</page-range>
            <pub-id pub-id-type="pmid">15126997</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r109">
          <label>109</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alpay</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sarici</surname>
                <given-names>SU</given-names>
              </name>
              <name>
                <surname>Okutan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Erdem</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ozcan</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>G&#x000f6;k&#x000e7;ay</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice.</article-title>
            <source>Acta Paediatr</source>
            <year>1999</year>
            <month>Feb</month>
            <volume>88</volume>
            <issue>2</issue>
            <fpage>216</fpage>
            <page-range>216-9</page-range>
            <pub-id pub-id-type="pmid">10102158</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r110">
          <label>110</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gottstein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cooke</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn.</article-title>
            <source>Arch Dis Child Fetal Neonatal Ed</source>
            <year>2003</year>
            <month>Jan</month>
            <volume>88</volume>
            <issue>1</issue>
            <fpage>F6</fpage>
            <page-range>F6-10</page-range>
            <pub-id pub-id-type="pmid">12496219</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r111">
          <label>111</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ohi</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Surgery for biliary atresia.</article-title>
            <source>Liver</source>
            <year>2001</year>
            <month>Jun</month>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>175</fpage>
            <page-range>175-82</page-range>
            <pub-id pub-id-type="pmid">11422780</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r112">
          <label>112</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karthik</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Campbell-Davidson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Isherwood</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Carotenemia in infancy and its association with prevalent feeding practices.</article-title>
            <source>Pediatr Dermatol</source>
            <year>2006</year>
            <season>Nov-Dec</season>
            <volume>23</volume>
            <issue>6</issue>
            <fpage>571</fpage>
            <page-range>571-3</page-range>
            <pub-id pub-id-type="pmid">17156001</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r113">
          <label>113</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Riskin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tamir</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kugelman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hemo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bader</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Is visual assessment of jaundice reliable as a screening tool to detect significant neonatal hyperbilirubinemia?</article-title>
            <source>J Pediatr</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>152</volume>
            <issue>6</issue>
            <fpage>782</fpage>
            <page-range>782-7, 787.e1-2</page-range>
            <pub-id pub-id-type="pmid">18492516</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r114">
          <label>114</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khurshid</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Sauve</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Universal screening for hyperbilirubinemia in term healthy newborns at discharge: A systematic review and meta-analysis.</article-title>
            <source>J Glob Health</source>
            <year>2022</year>
            <month>Dec</month>
            <day>29</day>
            <volume>12</volume>
            <fpage>12007</fpage>
            <pub-id pub-id-type="pmid">36579719</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r115">
          <label>115</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rand</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Karpen</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Malatack</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Sokol</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Whitington</surname>
                <given-names>PF</given-names>
              </name>
            </person-group>
            <article-title>Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin.</article-title>
            <source>J Pediatr</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>155</volume>
            <issue>4</issue>
            <fpage>566</fpage>
            <page-range>566-71</page-range>
            <pub-id pub-id-type="pmid">19560784</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r116">
          <label>116</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hank&#x000f8;</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Almaas</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lindstad</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rootwelt</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Bilirubin induces apoptosis and necrosis in human NT2-N neurons.</article-title>
            <source>Pediatr Res</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>57</volume>
            <issue>2</issue>
            <fpage>179</fpage>
            <page-range>179-84</page-range>
            <pub-id pub-id-type="pmid">15611354</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23803.r117">
          <label>117</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Olusanya</surname>
                <given-names>BO</given-names>
              </name>
              <name>
                <surname>Slusher</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Imosemi</surname>
                <given-names>DO</given-names>
              </name>
              <name>
                <surname>Emokpae</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Maternal detection of neonatal jaundice during birth hospitalization using a novel two-color icterometer.</article-title>
            <source>PLoS One</source>
            <year>2017</year>
            <volume>12</volume>
            <issue>8</issue>
            <fpage>e0183882</fpage>
            <pub-id pub-id-type="pmid">28837635</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
